%PDF-1.3
%
11 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
13 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ ! p )P
endstream
endobj
14 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
12 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ ! p )P
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
16 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
9 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ ! p )P
endstream
endobj
15 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ ! p )P
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
10 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ ! p )P
endstream
endobj
18 0 obj
<>stream
2014-01-02T07:45:09+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2016-04-28T01:19:56-07:00
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
application/pdf
untitled
uuid:16c8f8b0-be7c-41d2-b159-819b3de306f4
uuid:0ec3aaa9-6923-4f1e-ae42-0e51ad2a926c
endstream
endobj
19 0 obj
<>stream
x+ |
endstream
endobj
20 0 obj
<>stream
xS**T0T0 B iU D* :
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS**T0T0 B iU !D. _e1
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 B iUD* 8
endstream
endobj
25 0 obj
<>stream
x+ |
endstream
endobj
26 0 obj
<>stream
xS**T0T0 B iU)D* 9V
endstream
endobj
27 0 obj
<>stream
x+ |
endstream
endobj
28 0 obj
<>stream
xS**T0T0 B ih] D. pa
endstream
endobj
30 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
8.9663 0 0 8.9663 59.7543 725.7825 Tm
0 0 0 1 k
0 Tc
0 Tw
[(written)-351.5(informed)-346.4(consent)-351.9(from)-342.9(all)-341.7(of)-351(the)-345.2(participants)-349.5(in)-342(our)]TJ
0 -1.2203 TD
[(study.)-247.4(Between)-242.1(June)-245.4(2011)-244.6(and)-239.8(December)-243.3(2012,)-241.2(we)-241.8(performed)]TJ
0 -1.2266 TD
[(LESS)-199(retroperitoneoscopic)-210.2(adrenalectomy)-203.6(for)-193.6(16)-201.4(patients)-199.6(with)]TJ
0 -1.2203 TD
[(pheochromocytoma)-422.6(including)-411.1(seven)-416.2(men)-411.8(and)-410.6(nine)-408.5(women)]TJ
T*
[(with)-489.6(a)-486.4(median)-487.4(age)-490.7(of)-490.1(39.4)-482(years)-492.7(\(range)-488.9(2058)-484.4(years\).)-489.8(All)]TJ
0 -1.2266 TD
[(procedures)-212.6(were)-210.8(performed)-215(by)-204.8(the)-212.4(same)-206.9(experienced)-215.3(surgeon)]TJ
0 -1.2203 TD
[(\(XC\))-308.8(and,)-306(in)-304.1(all)-303.8(patients,)-310(the)-300.9(diameter)-308.1(of)-306.7(the)-307.3(pheochromocy-)]TJ
T*
[(toma)-335.4(was)-331.2(less)-328.5(than)-335.5(4.0)-166.3(cm.)-328.6(Patients)-338.7(who)-330.3(had)-328.4(bilateral)-337.6(pheo-)]TJ
0 -1.2266 TD
[(chromocytomas)-365.9(or)-357.6(for)-358(whom)-359.4(there)-364.8(was)-356.5(a)-359.9(high)-362.5(suspicion)-359.3(of)]TJ
0 -1.2203 TD
[(malignancy)-284.1(were)-280.3(excluded)-284(from)-279.7(this)-286.9(study.)]TJ
1.1128 -1.2203 TD
[(All)-267.7(patients)-262.9(were)-267.7(evaluated)-267.2(by)-261.8(MRI)-264.4(or)-269(CT)-262.4(abdominal)-263.8(scan)]TJ
-1.1128 -1.2203 TD
(and/or)Tj
6.7246 0 0 5.9768 91.8425 609.2219 Tm
(131)Tj
8.9663 0 0 8.9663 101.9338 605.2534 Tm
[(Imetaiodobenzylguanidine)-376.7(preoperatively.)-375.8(Bio-)]TJ
-4.7042 -1.2266 TD
[(chemical)-353.8(assessment)-353.8(included)-352.1(plasma)-350.6(and)-353.7(urinary)-348.7(catechol-)]TJ
0 -1.2203 TD
[(amine)-832.2(concentration)-840.8(and/or)-828(concentrations)-842.2(of)-831.5(24-hour)]TJ
T*
[(urinary)-462.5(vanillylmandelic)-455.5(acid.)-457.2(All)-457.4(patients)-458.9(received)-462.2(alpha-)]TJ
0 -1.2266 TD
[(blockade)-389.9(\(prazosin)-391.9(or)-389.2(phenoxybenzamine\))-395.7(at)-385.7(least)-390.4(2)-391.5(weeks)]TJ
0 -1.2203 TD
[(before)-507.7(surgery,)-502.6(and)-505.4(eight)-504.9(patients)-509.4(received)-506.5(betablockade)]TJ
T*
[(\(metoprolol)-578.6(or)-572.5(labetalol\))-574.1(when)-571(cardiac)-567.6(arrhythmias)-577.2(were)]TJ
0 -1.2266 TD
[(prominent.)-445.9(We)-447.8(recorded)-439.2(the)-446.4(surgical)-443.6(details,)-444.1(perioperative)]TJ
0 -1.2203 TD
[(complications,)-565(and)-562.3(postoperative)-564.9(data.)-561.8(Intraoperative)-565.2(hy-)]TJ
T*
[(pertension)-604.7(was)-603.1(de ned)-600.2(as)-601.5(systolic)-598.3(blood)-604.5(pressure)-600.9(\(SBP\))]TJ
T*
[(higher)-230.3(than)-221.7(180)-169.3(mm)-222.8(Hg,)-222.3(and)-220.9(hypotension)-229(was)-223.8(de ned)-227.2(as)-222.1(SBP)]TJ
0 -1.2266 TD
[(lower)-286.7(than)-278.6(80)-169.7(mm)-279.7(Hg.)]TJ
/F9 1 Tf
0 -2.4406 TD
[(Operative)-339(technique)]TJ
/F5 1 Tf
1.1128 -1.8336 TD
[(Patients)-288.1(were)-280.3(placed)-284.8(in)-278.8(the)-282(lateral)-285.4(decubitus)-286.5(position)-284.7(with)]TJ
-1.1128 -1.2266 TD
[(appropriate)-447.4( exion)-444.7(under)-444.6(general)-447.6(anesthesia.)-445.1(A)-444(2.53.0)-161.5(cm)]TJ
0 -1.2203 TD
[(transverse)-273.5(skin)-271.9(incision)-273.7(was)-268(made)-265.5(along)-272.9(the)-269.3(lower)-267.8(margin)-268.4(of)]TJ
T*
[(the)-187.1(12th)-186.2(rib)-185.7(in)-184(the)-187.1(midaxillary)-185.4(line.)-184(Vessel)-192.1(forceps)-189.2(were)-185.5(used)-182.6(to)]TJ
0 -1.2266 TD
[(bluntly)-280.4(dissect)-274.4(the)-275.6(fascia)-275.5(and)-271.5(muscle,)-277.8(and)-271.5(the)-275.6(retroperitoneal)]TJ
0 -1.2203 TD
[(space)-412.4(was)-413.4(initially)-417.5(developed)-412.4(by)-407.2(blunt)-417.8( nger)-409.7(dissection)-416.9(as)]TJ
28.0042 37.2799 TD
[(previously)-620.3(described.)]TJ
6.7246 0 0 5.9768 398.381 729.751 Tm
(9)Tj
8.9663 0 0 8.9663 407.2818 725.7825 Tm
[(A)-614.7(single-port)-622.5(access)-620.2(\(Shikonghou,)]TJ
-10.7553 -1.2203 TD
[(Hangzhou)-248.3(Tonglu,)-249(China\))-250.7(was)-249.1(placed)-253.2(in)-247.2(the)-250.3(lumbar)-247.4(incision.)]TJ
0 -1.2266 TD
[(After)-413.9(insuf ation)-414.8(of)-414.2(the)-408.4(retroperitoneal)-417.9(cavity)-412.6(with)-413.7(CO)]TJ
6.7246 0 0 5.9768 535.5211 702.3683 Tm
(2)Tj
8.9663 0 0 8.9663 542.551 703.8423 Tm
(at)Tj
-25.8417 -1.2203 TD
[(1214)-162(mm)-311.3(Hg,)-317.1(a)-309.3(10-mm)-310.8(30-degree)-317.1(rigid)-312.4(laparoscope)-315.5(was)-312.3(in-)]TJ
T*
[(serted)-226.6(through)-231.5(the)-231.4(10-mm)-228.6(lumina)-230.2(for)-225.2(monitoring.)-234.1(A)-229(standard)]TJ
0 -1.2266 TD
[(straight)-399.5(instrument)-404.1(and)-404.2(a)-397.9(curved)-403.3(instrument)-404.1(were)-400.5(then)-399.2(in-)]TJ
0 -1.2203 TD
[(serted)-365.7(under)-368.7(direct)-361(visualization)-370.5(to)-363.6(perform)-370.2(the)-364.2(procedures)]TJ
T*
[(\(Fig.)-281.3(1\).)-287.4(The)-284.5(standard)-289.1(straight)-285.7(instruments)-291.6(were)-286.7(5)-170.2(c)0(m)-281.4(shorter)]TJ
0 -1.2266 TD
[(than)-278.6(the)-282(curved)-283.2(instruments)-285.3(to)-281.4(minimize)-286.7(interaction.)]TJ
1.1128 -1.2203 TD
[(In)13.5(ter)11.6(nal)12.5(ly,)-219.5(the)-225.1(ope)14.9(ra)12.4(tive)-219.6(pro)14.1(cedu)15.4(re)-228.2(du)14.6(plic)17.6(ate)12.8(s)-235.3(con)13.5(ve)12(nti)11.6(ona)13.3(l)]TJ
-1.1128 -1.2203 TD
[(re)12.1(trop)13.7(er)12.1(ito)12.2(neo)12.9(sc)12(opi)11.3(c)-385(adr)15.8(enal)19(ect)13(omy)-377.8(for)-377(phe)14.3(och)13.5(rom)11.6(ocy)12.5(tom)18.2(a.)]TJ
T*
[(Aft)16.6(er)-266.2(diss)16.1(ect)13(in)12.1(g)-270(and)-258.8(rem)14.5(ovi)11.9(ng)-267(som)17.3(e)-271.8(o)0(f)-262.5(the)-263(ret)11.6(rop)14.1(er)12.1(ito)12.2(neal)-259.2(fa)12.7(t)]TJ
0 -1.2266 TD
[(and)-271.5(adj)17.8(ace)14(nt)-282.1(ti)15(ssue)15.1(,)-281.1(the)-275.6(Ge)14(rota)-269(fas)11.4(cia)-267.9(was)-274.3(the)15.2(n)-281.6(open)17.9(ed)-281.1(lo)12.7(ngi)14(-)]TJ
0 -1.2203 TD
[(tud)14.1(in)12.1(all)12.4(y.)-171.7(The)-170.7(diss)16.1(ec)13.5(tio)12.2(n)-180.4(was)-166.8(eff)11.8(ect)13(ed)-173.6(by)-173.2(blun)12.6(t)-177.5(i)0(d)12.4(enti)18( cat)16.7(ion)-167.8(of)]TJ
T*
[(the)-459(plan)17.5(e)-474.1(bet)14.2(wee)11.2(n)-471.3(the)-465.3(pe)11.4(rir)14(ena)16.2(l)-471.4(fat)-468.3(and)-461.2(the)-459(ante)15.7(rio)12(r)-468.6(rena)15.5(l)]TJ
0 -1.2266 TD
[(fa)12.7(sci)14.8(a,)-192.1(and)-189.3(an)-186.3(ult)13.6(raso)14.7(ni)12(c)-195.3(sca)12.5(lpe)14.2(l)-193.2(was)-185.8(used)-182.6(to)-192.9(sha)14.8(rpl)13.4(y)-194.1(divi)20.8(de)-192.6(the)]TJ
0 -1.2203 TD
[(tis)13.7(sue)16.4(.)-306.4(T)0(h)12.6(e)-303.4(sup)14.9(eri)14.8(or)-300.6(pol)17.6(e)-303.4(o)0(f)-300.4(the)-294.6(kid)20.7(ney)-298.6(was)-287(expo)12.8(se)11.4(d,)-296.8(and)-290.4(the)]TJ
T*
[(mas)14.3(s)-260.6(was)-249(the)15.2(n)-262.6(v)0(i)14.7(sibl)18.8(e.)-255.7(Sur)12.1(rou)14.1(ndi)15.4(ng)-254.4(fat)-253.4(or)-256.4(adj)17.8(ace)14(nt)-256.8(tis)13.7(sue)-249.2(was)]TJ
0 -1.2266 TD
[(use)16.4(d)-331.8(t)0(o)-325.7(m)0(a)15.6(nipu)15.7(lat)15.5(e)-328.7(the)-326.2(ma)15.6(ss)-325.1(and)-322(the)-319.9(adr)15.8(ena)16.2(l)-332.3(gla)17.8(nd)-328.9(to)-319.4(mini)17.3(-)]TJ
0 -1.2203 TD
[(miz)18.4(e)-221.2(bloo)18.1(d)-224.3(pres)15.7(sur)15.6(e)-221.2( uc)15.3(tua)11.3(tio)12.2(ns)-219.7(and)-208.2(blee)17.5(di)12.4(ng.)-213.1(Aft)10.3(er)-215.6(the)-212.4(mas)14.3(s)]TJ
T*
[(was)-672.7(alm)18.4(ost)-674.8(com)13(pl)14.1(ete)12.4(ly)-678.2(diss)16.1(ec)13.5(ted,)-670.2(the)-674(adr)15.8(ena)16.2(l)-686.4(v)0(e)12(i)0(n)-677.2(was)]TJ
T*
[(cla)16.6(mpe)13.8(d)-300.2(wit)13.3(h)-300.6(2)-303(He)12.8(m-o)11.8(-lo)12.2(k)-301.6(cli)18.9(ps)-299.8(\(We)13.3(ck)-294.5(Clo)12.5(sur)15.6(e)-303.4(Sys)14.8(tem)14.7(s,)-295.1(Re-)]TJ
0 -1.2266 TD
[(se)11.4(arc)13.2(h)-401.7(Tria)18.5(ngl)14(e)-398.2(Park)19.3(,)-401.3(NC\))-392.6(and)-391.6(di)12.4(vide)18.1(d.)-397.9(Aft)10.3(er)-392.6(rese)17.2(ctio)19.2(n,)-398.3(the)]TJ
0 -1.2203 TD
[(spe)16.4(cim)12.3(en)-376.3(was)-375.5(ca)13.9(ptur)15.1(ed)-375.9(in)-380(a)-378.9(cust)16.5(om-)11.8(mad)12.6(e)-379.3(lap)14.6(aro)16(scop)14.2(ic)-375.9(bag)]TJ
T*
[(and)-467.5(re)12(tri)14.3(eve)12.1(d)-477.2(thr)14.4(ough)-467.2(the)-465.3(sing)19(le-p)13.7(ort)-465.5(sit)13.6(e.)-477(A)-475.6(rub)12.5(be)14.7(r)-481.2(dra)15.8(in)]TJ
0 -1.2266 TD
[(pla)14.6(ced)-267.7(thr)14.4(oug)16.7(h)-275.3(the)-269.3(inc)12.8(isi)16.9(on)-271.7(was)-268(lef)15.1(t)]TJ
/F10 1 Tf
15.8452 0 TD
[(in)-271.9(sit)15.9(u)]TJ
/F5 1 Tf
2.8833 0 TD
[(whe)14.1(n)-275.3(nece)16.5(ssa)16.8(ry.)]TJ
/F3 1 Tf
-18.7285 -2.4406 TD
(Results)Tj
/F5 1 Tf
1.1128 -1.8336 TD
[(Table)-294.9(1)-303(summarizes)-299.4(the)-307.3(demographic,)-302.9(intraoperative,)-303.9(and)]TJ
-1.1128 -1.2266 TD
[(postoperative)-400.5(data)-400.8(of)-401.6(the)-395.8(patients.)-404.9(No)-401.1(conversions)-398.5(to)-401.6(open)]TJ
0 -1.2203 TD
[(surgery)-215.1(or)-212.1(standard)-219.6(laparoscopy)-212.5(with)-217.7(additional)-218.3(trocars)-213.4(were)]TJ
T*
[(necessary.)-455.2(The)-455.2(mean)-455.6(operative)-464.1(duration)-457.3(was)-451.4(68.1)-456.7(minutes)]TJ
T*
[(\(range)-590.1(41125)-167.8(min\).)-589.6(The)-588(mean)-588.4(blood)-591.9(loss)-590.6(was)-590.5(negligible)]TJ
0 -1.2266 TD
(\()Tj
/F6 1 Tf
.4869 0 TD
(<)Tj
/F5 1 Tf
.7208 0 TD
[(50)-163.4(mL\),)-611(and)-612.9(no)-613.2(patient)-615.6(needed)-609.8(blood)-617.2(transfusion.)-615.5(In-)]TJ
-1.2077 -1.2203 TD
[(traoperative)-774.6(hypertension)-777(\(SBP)]TJ
/F6 1 Tf
15.6049 0 TD
(>)Tj
/F5 1 Tf
.5501 0 TD
[(180)-169.2(mm)-766.5(Hg\))-776.3(occurred)]TJ
-16.155 -1.2203 TD
[(in)-247.2(12.5%)-243.4(\(2/16\))-242.7(of)-249.8(the)-244(patients.)-253.1(A)-241.7(single)-250(episode)-245.7(was)-249.1(noted)-243.5(in)]TJ
0 -1.2266 TD
[(one)-391.8(patient)-388(during)-389.4(intubation)-395.9(and)-391.6(two)-390.6(episodes)-392.5(in)-386.3(another)]TJ
0 -1.2203 TD
[(patient)-211(during)-206.1(tumor)-211.5(manipulation.)-212.5(No)-211.4(patient)-211(had)-208.2(sustained)]TJ
ET
q
1 i
60.491 360.567 m
298.148 360.567 l
298.148 123.874 l
60.491 123.874 l
W n
q
237.657 0 0 236.693 60.491 123.874 cm
/Im1 Do
Q
Q
BT
/F7 1 Tf
8.9663 0 0 8.9663 59.7543 107.0929 Tm
[(FIG.)-362.1(1.)]TJ
/F5 1 Tf
4.1225 0 TD
[(A)-355.5(single-port)-363.3(access)-361(\(Shikonghou,)-366.4(Hangzhou)-362.1(Ton-)]TJ
-4.1225 -1.1065 TD
[(glu,)-505.4(China\))-503.6(was)-502(placed)-506.1(in)-500.1(the)-503.3(lumbar)-506.6(incision.)-504.2(A)-500.9(10-mm)]TJ
0 -1.1128 TD
[(30-degree)-260.2(rigid)-255.5(laparoscope)-258.6(was)-255.4(inserted)-258.8(through)-263.1(the)-256.7(10-mm)]TJ
T*
[(lumina)-268.1(for)-269.5(monitoring.)-265.7(A)-267(standard)-270.1(straight)-266.7(instrument)-271.3(and)-265.1(a)]TJ
T*
[(curved)-447.6(instrument)-448.4(were)-444.7(then)-449.7(inserted)-448.5(to)-439.5(perform)-446.1(the)-446.4(pro-)]TJ
0 -1.1065 TD
(cedures.)Tj
ET
310.847 266.4 239.074 .22675 re
f
310.847 78.066 239.074 .22681 re
f
BT
/F8 1 Tf
8.9663 0 0 8.9663 345.5999 282.0472 Tm
(Table)Tj
/F5 1 Tf
3.0603 0 TD
(1.)Tj
/F8 1 Tf
1.2519 0 TD
[(Demographic,)-334.5(Intraoperative,)]TJ
-3.7495 -1.1128 TD
[(and)-331.7(Postoperative)-340.2(Data)-334.7(of)-330(Patients)]TJ
/F5 1 Tf
-4.4387 -2.0423 TD
[(Sex)-335.7(\()-82.7(M/F\),)]TJ
/F10 1 Tf
5.2354 0 TD
(n)Tj
/F5 1 Tf
17.2615 0 TD
(7/9)Tj
-22.4969 -1.1128 TD
[(Mean)-330.4(\(range\))]TJ
.999 -1.1128 TD
[(Age,)-331.1(years)-14245(39.4)-336.6(\(2058\))]TJ
T*
[(BMI,)-335.6(kg/m)]TJ
6.7246 0 0 5.9768 364.9889 227.8488 Tm
(2)Tj
8.9663 0 0 8.9663 489.5999 223.8236 Tm
[(27.6)-336.6(\(21.538.3\))]TJ
-19.9361 -1.1065 TD
[(Tumor)-334.2(size,)-336(cm)-13540.5(3.3)-337.1(\(2.13.9\))]TJ
0 -1.1128 TD
[(Tumor)-334.2(side)-336.5(\(right/left\),)]TJ
/F10 1 Tf
10.7806 0 TD
(n)Tj
/F5 1 Tf
11.4698 0 TD
(5/11)Tj
-22.2503 -1.1128 TD
[(Operative)-337.9(duration,)-333.8(min)-9128.4(68.1)-336.6(\(41125\))]TJ
T*
[(EBL,)-334.4(mL)-16813.2(38)-334.1(\(2095\))]TJ
0 -1.1065 TD
(SBP,)Tj
/F10 1 Tf
2.3015 0 TD
(n)Tj
/F5 1 Tf
.8852 0 TD
(\(%\))Tj
/F6 1 Tf
-2.0233 -1.1128 TD
(>)Tj
/F5 1 Tf
.5564 0 TD
[(180)-162.9(mm)-336.6(Hg)-14344.8(2)-334.6(\(12.5\))]TJ
/F6 1 Tf
-.5564 -1.1128 TD
(<)Tj
/F5 1 Tf
.607 0 TD
[(80)-169.7(mm)-330.2(Hg)-16658.9(0)]TJ
-1.7704 -1.1065 TD
[(No.)-334.5(of)-332(complications)-13833.9(2)]TJ
.999 -1.1128 TD
[(Peritoneal)-337.5(tear)-15630.8(1)]TJ
T*
[(Pneumonia)-17059.3(1)]TJ
-.999 -1.1128 TD
[(Morphine)-336.3(equivalent)-339.2(\(mg\))-8741.2(4.7)-337.1(\(015\))]TJ
0 -1.1065 TD
[(Mean)-330.4(\(range\))]TJ
0 -1.1128 TD
[(Resumption)-338.4(of)-332(oral)-335.3(intake,)-336.6(days)-6179.4(1.2)-337.1(\(12\))]TJ
T*
[(Hospital)-334.9(stay)-334.5(after)-336.2(operation,)-339.8(days)-5022.3(3.1)-337.1(\(25\))]TJ
7.9702 0 0 7.9702 318.7841 66.2173 Tm
(BMI)Tj
/F6 1 Tf
2.0415 0 TD
(=)Tj
/F5 1 Tf
.7113 0 TD
[(body)-318.9(mass)-318.2(index;)-316.8(EBL)]TJ
/F6 1 Tf
10.0651 0 TD
(=)Tj
/F5 1 Tf
.7184 0 TD
[(estimated)-317.8(blood)-312(loss;)-322.4(SBP)]TJ
/F6 1 Tf
11.509 0 TD
(=)Tj
/F5 1 Tf
.7184 0 TD
(systolic)Tj
-26.7596 -1.1239 TD
[(blood)-326.3(pressure.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(LESS)-340.8(ADRENALECTOMY)-336.4(FOR)-334(PHEOCHROMOCYTOMA)-26973.6(57)]TJ
ET
endstream
endobj
33 0 obj
<>stream
Adobe d C
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? VͿų~2N< -4aIC Uu?hP(O5@S
. <[Զ ]@b> _ w PBӯG5r&M0/~$>T#[Q -ᕍAyahiF" "Pa͛ j?dcJ] XԖ9 ⛵<<0! ! 0M¸1ȼ֝r#UOxڑ {a`k('{ dO[rԧ!& S8QBPm&@^k [ը cSmRkdz ՚gAQV 7XYxyɡ^G<
7~Ċqg7 1?,OWoR }OraE wY?{RV a8ah3W- N4w=8Ȕw qocs| '8݆)* :3F.42)d#0,:q,gRѷ bJ߮[Y KN${v86 JےiS-&!18.)!oSU= XV ^N)*I"5;*rgm f| OMO÷{aiF &o-ݜwpDeV~Lu+u,[O-=p>`HsXY1HmT,j>ʀsyc~gdps"ЎL*} cB m))DJ&/j 2Š_#QN; jx
f`V'UX+"ڝU'sL0´e+'
u;л l1ܳ$gj7у.Psa
M\@yWoƠ{bv8B8QwpUVkt
d Ȍ]$Wb*r?qv"z
IҬtC<c
myX}Yn)ަ
bUw?!:?2Q)㓴<8[2ƥɧpۏL%fk{}WE4 ϒ_UEk7w|mRA3<@t1[O `={z,o (xx8GQ^ VUq5*zt?heISrSׇ9ifi}G: |`Q@8eFGn
d7Nm(t* DuVsm5ۙ-%{y~źj: z
~
N~VEENyƕl7*SGJ`kT[+@~ w 8+UǤGvZ82)?_`-n5=2,mٔuΩ ̱(1A*cŮj )Pl> l*BjO}bY丐 d
V jZY(Bh=rgɇM XTSo [_Yח7 4) ? ƹt S@<03Z/NDztZJWDmOjgU[]D?,tr#?eW\ H1 jĕ1EA=^GTaݿQJ{?Kt6"ZoWcՈp( R4,E _a Ti}1M^HHTQC{`f#~ZW"r6Z4|w
Fi%$lz+2)[G oLX"*Gcc ;{"8Z&4
%tFf]#^f:HHe~jC VpHjv.ⴍ!C
&B*kp}Lf08lw\
Ka`IRHnM:|68.)LRv|pZI hqZ;l
m Ti\y><Ўʂ(oKJWZl0(Yj|~@0ï]]$n*h퐻%1ؒ 4- `1 cP{d/M|mspOEôwMz
|*0R7x ;QTnC!ZK_.Z
DƳuck+ Hb?0pwoVJ
4}*/ H X_>V=I2 Utpgma'X',6$gh3 !/xeicO-U湈ᅇLbn2Vx떷zU!AYWƃ 5Xk1ߗBVU^#sצ%ad$EkQ] Gbv4o/[Q_쯶 w#l Ƒlw=ODi(#aIIu0K/B?-n#5^ c-Dw6ȡnqY5XeN_ `>!PK(b Sz0WF&m۱MN#!aM
K}i=G8% |5 _? ]_S [o
MEz-`kZ;c$#u-8x WO/LImg/vɗ5 S~ \
+ʦ|F *ٽ [!! ڇ;GND2{uxB[XC jx J6R.>w}b1 ɝb TW $> sH^[t
b,Ët G/#1ni6|7^H+do˚v2 > 3yVW :`uu j(KFG 7S47)d= 8}Qm@ ).:~27'E1 A페FP~{adH )QEtK+MprH*E\)jwb}1Tu>VfPm*B u;fy# |1pJ.lN
d ؎ouz)Qj#>4m|A0T(5[W8^]18/ >/øyw ZG3U+rZqyn>2SB ͫT5Ƨ촭.iѭw 2LcbK kQ^k0m!ڂ~x g_)OكRzǮHG;3e+ S 琡?<|o\H[K O
|[Vg)ڸYq,NcE: !o5~ ~bn")D?h q,W>٬& %ͱQaJM\z ^6)tOZr6dAC+ Ts 0
l$SE'WQ̍ɥ0S"z 2̬(MQ팴ҽp]+2 M 3"|K,N9v 5)d}2T܆ 4ʊ $X4]wT8 M
A4\HËV4UV ᆚCrO C4A =q Vz-k2q*Fiʦq$mK#1bGikP0Ǩ7cE`FRIo7T_ZJcڿ<:躴VK&4B$arO^TRPj:-zw9 [/AOvSr?8s]zr FV(7bp59io15ep5r "t'2ЭN:+\=z(:/CK86j˅0Q RR+ƮzMA#l>dDk1vHb~VH[~
wawT#P OdS#zR7 D܉BܫMrcOL34$zhYURP!02WRiAb6}x+]Z3L|21}qyy)$<:SA0,LxP 4_0UP7A-![TnI`S VNw遭Wh+w8:4- ?QLLM|;`K
Yش&DSjn0X`qƼG \ehU#c4$ BzYNB pWA;Hd YAS H sX6 ̈́x̛a'shqwL}]&Crwv]9=,AR(֊ [&k9 2{ ~d~kG6He}Vu?Vbz;|j02M ߍ_ AE'a^ݰ~qoiH* N<ھI8;ȑogH_Myˬ4|3B 'yvIgZ.
NcMtI*|rA \Vʆ( ƛX,3֦ -bN V#s%84 5;
sbZ\ [fde?}8Oi =Bh
w9 o$զ
F!#]vq%*Ií> <
Zjk83zz2hrQ
bzC prVJ3҈o"4|Lya$=: hO\p(!>ؑM3? |]
ֵ)~n@7R MSVk+
zeveK8^0ČF
W9o{e IjGq0Bk$ )`LT| iQAq:4똹 -Әa{MU|ȍQEw 9285h>xc
p&sŴl 2EW[\^L}bLdUQz7dyS#ol1awUM ' ^1@jMN(rˉ%z
@u:cTwW9 , ; k^. &ۯAu0ڒh`XyEB8}B^w(K7U;ʞsAQb@
61ҮGӁYڵ ,;#k(i/
awRHtj.H< m9@[SL%tzDZvchuC{z4R^Gsnv"(v-.uO9PA'1UxYƗp@2 뗓܆v12N 5]E>B<|5I[F(1OF#C'CA\XQZ Tz 7'[yoW2= ژc μ~;-~.Ie_Qޜ» u
ك{WG5/3:I `|zHbowȓ~կF2]Njfcea' ,5
b"sH(^MFn,~CUmm^5[ C`Ď 59lTOCHȹ m rh\ bq"+X
btAjכcC$]H5|0Wҗ`818hn.NR۠8 C*NNBF7+[L.۾-V@Z;QojM{IK~
8Ł#+6 ? hfxQi(H Maω/~"o0]OlO2XȲ5XOmW>$zr)_?,e Hp)_ nzaE#P#iWk(*':129 Ag$I¿8VrAʹ=? +WHZ\k˗U '96sZFLv}'"$9ѴC>ZDx/;qxd*REyMc^T30|= lI o§j ]{LFߗyɤ+_ 6-dC+(f5g5$>K- ~Vg` гnJɴPy{BN0+>3S9VSEN^YDJ{ 0~go/G(X%$cG2$= j } .6鿖^bo&>҄-#{*4ۏ:5Οl I ?aNvF_Ww?Iu;γ;H*DZm^cm4ޤ|9]%a5KUR`ZT7,yO閠x/? :y^_^) #0)j5sGM&fZS"Qݛ·Ѻ4| Glqk hҤ^OL wT_s$OR{ M 9Q_ vk,U;֣],Sy~=$cZ? F&q[x$u؛/j#:Xj0G}a3qGhWwlIӭzi$, Aoy5O&^ AK5;^9+Pmg_v2KM&kNd'X[)n>x$d҃sjڎ}[]zp}Y+U ߧ vL,,4.; 0|L~ӷvosN!T/ zo
5]F٭FQҵ=P PF4Ƃ 3z +z ,Id~nKrI-¤H] }6/2SI\[caZmZ:~ iLQQ4 B\>(b |x̶I:
4 5ʓL[ ȝHzB ڰZ3^O5~GYjKm8GsiY~ARE(Ċ 5VPw_QubHxUaNiZntd'
j'BY`bꬦiZܱ7cixN,z~x\4-vb۶x 8 |L~X5 6FߎIdi k@QG@w ]5Dp1;JĊTn0[Sd^v-f.z( 75\K`;`m9]FZ"vII#YV{T
JBXa}đsiO0k²0e4cZ-g)NCsd#&|0m}NU&OcZv89NFIuh?Eڧl.GL> Slm cjp:f9B%ɯYh7IuL"Ojmʞ;VԞ)!_zkI[V
v:/͢+wVaI?ϹɾEY Yg?%z#J c %8bypF(|ͭ/E1>ԒS=fm
!v;8!g# iJ`KMڱ;pQŹhƔD_|w+;9,w8 }JC|> +H5R ?Onj W^ >҉q2
'J0
Kv;mt/yvѵ;ijܰ} aľm1; ;%]'"4-&B鏫!+sZ]\ȱ;ʪ*N ͧ[1ԅ 8GFOJ4O<-J%<'QGJ#
̱ζ ˊj³|@: K(i
6fH:a![U##wWO pOK+x#pEp|G.0\~b)$;j=s$72O+V/#f5'ݟL>%v$B{ŧ,Ѣ\3aBΈWFKbY\STlX fb5a-[)#;" ymw-lvM죾̱>oVW ˑM4[5`
ixhx:R:k_3\Qp/4DԨp~X15p{t `p|zʘ٘@|ݼKd~n /oUi H2;9-e чS9ڄ݃X*z VJ Kk恭@eaN-"ZA4kr#QG
d˺BbcX0QZH PM5. ~ lɒ{}5
BVo>jv@ԌeПLc_T/ * {5zOng$mLvt{o[yRIMw՚AXÂ\ceQ)O j L
LsFX̦#~y]݃q{i,݉&0HMLpĥclǩ ܖE%Y0-l J%×WlXqLmA0 {`# :vag!mdrA[ݚ>y~ʱL5{^De#ޘ̌xS_ X`%ZK0H |u n#Ǩ>#q ,i5X
|Me(b%ɿ/l)&` =;_
xvŬW8gP}]:0Y2* *QKc3-JR{i
8=b89ĴXP17Q$fy~PTgZtQ(4m SԮ&;xssIhuM]=~ ?g$_;K#K[y9[چ?f*Lj槒=ʋ}b[[q 3[i&O5}fS'=8ӢPL.5nGa$ v.>xohV=z Jh1 |E e=wiY |Lh:ܜ1Ju]bnڃLd,!J{W6XKy*AƽG=h e77>8ze'l%Ud; P[d#;y\<+qmaE/撿x`0T{cC
գ*}8M#`
1 u^M4Ɂ ӶFu ,G<~kDuCz`֨ |EfndA:4?
SC|S06+T8bON8#_sDL
@4ԧFjdΫ AcJ
v핤NįѶ"CNoa[ZLi4)r
duZu4jYsi( P05jLoxȬ> r?n<ojߦ/[k eSn`(ǂ1 g[C֡sUѯsgywpڜQ
2֖1̨O:wt}Cѷ m% ۵<' iڬ㉶횫;N= ݾ eS7\z${-#xdo˟WWouL#pRRP?Ѵ x~b@Rj HvNVܤjN@g?F+ar\GU>݈ rsr~
v"HI xPҷe(cdv}|( cI^1;f :whw `8Bۀ>g
I$d*V ! cCpJK 1U (/jYb 8j (}r6fL+eRZ6xIߗ2w`VLd
D Ƹ-< Zw.?.-4T-Bď>ݳ9PZ? 2QA&{r4b̨c߶
OAA$$wC42}#e*Ӵ@:ֲy텖\Z 5>] ՛O M?SbdR&f=Wn6-OP?d}?A==[
4ٙa Bƀ(C qqmcc! puTNFw#Wc^1p@AT |jV= yt4!Y5
|ugi-(8/ۑ=OlSCo0y[?v?Pw;Sϰ,Νi|Whfoz yu-( ~aets jt:m Cs/1 dC
s]0"RHCҽ+&(rȄV55&$&J7]00-. hVF ZT;x}Kgdq nע(!Cҩ?s:] *ۦ櫈/ KQ D OA8="ҀN(qrzk4In$e'p˚8䊰5M(
4kBd *~o-.6 +Z= ub1dD #E9V xjp I+~Nr|Nk2ʛ
l
/,>Ϫc[1SMuvv5#e_|irP4.{m˹}{W ]E Q᷇b|0yor>Eljxpu\4AŤzWl}xB,A! _ Sb*\mbӊ3 ?^^Xz*_WQM6VuxJ@Ƒ"\~A:wڂgӢƀm94
.JEP?r+f'8Dm5|
B @쁎 ,-uYuYPV!g1FY|?kl?4 e~RMnoS:@O_? ִ=R}-OGV@ "TENU-ޒ#Md8b[U!6u.Đhy&58mt8Gj/~3 xcc%+E{xNS[ aCw'%
sS1-`s,`zoA^GZpSɍ{SǨ/W
i֘2X
?g>[iʖ deݿ)9^;A8{>}J?oQ-Ts̓xV S?V [̬,N 0bIH8Eþ OL*oLMp)"S&%:~KP,buj(=T-"F[~THffIe'=[R;q5f
J[ˡ
R9w'%6[OH_{rUj }Klem~w+N+> +]J$}ei$V:^L| 8[\J$xaNnBk冨Y
+ܜ%[u%V5b<aU-+.%TCU E&k}b*6 m $)9TrtXiZdfJC rD>idTu]c u$H㵳O4"5 *eڕԥc9g o?)e$Ԛ^O!K|Hd\: D
iOבo|xFĝ_ .}"%K7bwRqOL:t >(8IVHKKd_qRNJ<=ܺy^*
OJ _A(( &ۋh-P?G%"5D0{`.nI5}ME'V#KV_ ,ra5?9,.x \a-v&4H>Sl5b2*[W[ܵR(]^_lyPFqY_!?q4FxPP6~s Y <opf^@5~.gX؟N)ƌ.{.ah~'InK)0
wp̘m&nsaE#S}E Z9 <\6I
Z݀6n[VTܰ푿'&p#`>eɮWz,kj/.vºV}I &݉죹οSZnommfK[i 5O YFnqF8P,b$"d?#}i鐴qDhAb|)"W% X-;>#CN}"y~c邓BuHS~ 8"zqtU9 `Bҭ]w8>BxZqoBY[hJ7N}6mc] b%ĝw'ZjwQ- ݼ\wsԜ0kՍ?Vr,tkJm2V%]|h? ! MP˭뚃D4OonBL') =MI6 B@@C 9 '<146y ;z~lqM*\j.%aj) (s`O0iq_7 j2 ##WH35<bV p$9)>0ulm2wb5}%#$1jbDc^80 ,[2oUV&M@ i BMGMMJ3-U TP1=SM0M - 7h
˕I@)S5m
>!K,=J` kn$[
@0>Ѩ|NK!UH9 J$P@n" 9G_C[6aa|hTO"ܬnhL {j0V-A)(
ϩ,6*N 䆉6O++݀}Aa U;cNju/%c,ğao4zֵ k+ܜOhWN閒eqZSe_aXJVjqD5GZ W8 .CHuo~R n& G :
Z )
` 3r?e@Ⱦ$1>{]\4Z;g8"靛
qBN+n7ɇ徇 zθg:GY&;SH6"N)
¸]DZķ',.6B m϶U@0{TmS1q Pq^ _:vo2ևz m FkddfCF;c+qHG-r09v8Ai
Jpn^ wFExO%aڙ"W",H@~W$\.xG.]!?w4.fBʴ9 1zMn`U¿ ]Xgoh R[_VЂR)cn_ͪ) `l VOH jNs^Zs&kżu= (0Daz|M%|
bfkf,ڒ0^'~IC9剙r?ԟ.fqB kR)> %]? ,[m[R c.
M1-m阜I~x=!#{;#i_pHmLEh7ޝbNUb2TF떖C2,InP<m+T@Ljշo捷_VH$K0=xև0+}VuK.Uԃ)!Y^H88U1wĜһ q069T9m ~e
r6o|7Y mf~efBZdkWK9
- Bz}gʖezFҌ9~F\KEuX-I /k3۵Mr$xWfѴMJԲ8ee_J:^ g#K 1)1 9AǺ)6ԫ gG'/<4-iMԆa ~&/yn ,-K|wQ'؟= ƳGĀ
PzvxN `ѷ <%fX]O~!:m>{vsX\J~&%Lmί*I됿6qb 45]-CP8E]5PwZF<=O]ųuK . /Rf}?}KSq0ڑ_0=n
>g-HtBn!Ԑ|%T*ו=@SA-H7ڼ$ᮅM̺OLx@s8yu$kyi1F5;mQ1bRy%7<pO[v?Ol]7o07 ~{)> +?y_l'uiUl]rC@=}:D Nr+ DENN[(
q|1ssnOG㈯\$4&E'&A67ai hPnCRis"B$V̀z5nT CԄ [h`hjg)pGN ?ѝt F ygڔ`U$c}PVcW5?䷏ߙiB UTЌfAp~esupvBd-+KX`}M촽;Jç Nrğrw:qv#?5' zpW
V#Wz3?żɾCWp>W]7; N5c
A2GJ B*/7ϑ|w=m$59>/hio-Bly}5+Vu}sT
̏,B"zs3 dnwjNy rjkdxa; 0ZZBji$X YUYQ" rw;kqx?Y9w h.&c h
6m]AWP> i-0MmP[Kˏ}`#SNn\{dpS}NnG遢R&6eH0S*5kA5r'? ٸ _y̗4CMWT|'Hpy[oN'шly#;~?PC'
6^]Եe۵z(ji :F_$y<2P vJ϶G|6iЂ!TSag۬riv븮ö
\>ǵ 2jw6,}WCav6o `:W:,>t--忆>P3&}n/,7
߂ȃĒ bO߆{FnuO
'RIܪㅦFH e刦 +ZW$~al¬17N}r &@d$c,!ى?^!w'==Th>x7mIe-W)SH;}ؑVtA%T|&$ 2^LhkYj b:/W[SgL! *k%ŔH9+R#8ϓaY9[4WC䋉k؋DVJ [|Zy[E-
k d|xUYn. <&ݸ_ SM'^NGz\"p[4KeQ
dvf;ScUS'`8%q=\ڇjdBdIJ 1m" !n u Navt Ÿ}E:V,SZ ~ M*j}.R#ݴM!ыYyWFlT+_<ߪ4~ Bϑ| Ei¡eI}[PlJoZ?ij|ݬ6!]dXn|j-!Cwټr?su{Ó]wos>VRI BU-7,F͎d<Լ{M2mo_D2 ̼ v2 ֧^8䱴hm!cp7TP=8ucq8
t1\k^*Z S}hIrXf@j ŷ
9MCV[{H7SWt{
T}QRMQXGyS֤!1YWaO
U!Z8ta |X ! -FVه%&whRY!ԯ
ӑ}cEAr=N- v\an2zyoC[*wHE & CP a| ikG nb6 d\:MdD^cˏm}j 䰣9}aL>"Q2
ԏfY"]"iBwC% NS@)Z' {m
hq@7Ʒʗe8N[cN1F~Y.!!Wp3n: ljyn{{)5hQAt }IX\x|T%"2 M.ױXe-ڿFx啤
FJ(*(%k+AKnE*:L $~%
c}ʐˍ/LP#a>}-,a=MҘiy+X-MAWҌќjW:̷W$7''ۛF q,
#P/m[ӦKҕUX 2z*'Ƨdjkޤ? 1+P`0 ln
q i\ ֿ0.ۡ$9>|-u)o,K-$LSOX2D[%>>`;{d3I&? Yk.<}U5V=N]1Z|E{7lJSJErϩKl0 J8Vysɞ_j\T*|5&V?wAG, ֵt8jiwkL
{ %\x콤 <WDH&ҵX.(DS~폇*5)6RDNH-FN PA iL ]
!! ph)];iR-HTliZ o$2;|JKw8a"JSNNZƇdgwP=醷K
J-8[O aE;Rю{D Nj*?^B`Ӿ.O$w4'Pqxe"sJDO| v%b 8*8EMw8%FؓW~R:w۟lz O CM9{V_4ϜQףnk[O[*"48w(~\y%ρXi O}m<眓Q*dbqA%\ !?8 !}ώIq4uVrčW K~3b =G xu^\oN@#jxIi^ JKdX"j
!^u"@(OȬW,{`K$&Nc;<(zKI(E~(}de!OJ{%%s{ \Hҵ;"]q-y\.~j0Zհ&;j~*pQF9+#RzU,×HnbRvE0/K_q ?;Ӻ@pS_6 % WɁ##y^t)mf_c'U!%@J~d#b$jWq=ܑ[G,gnK"i7|Q#1?*
F
_Q/!"B=p6WUG6ӑ@Q&qXfE+GBG7Z ,? 74ɎK
DҸ?wr K)H49*N'6 $`|>
AW%[Zd,0^=\\T[#PEu' IִĦȀ n\ǬT@+N m[cdb^;UAң|jNian qC0[
<;h3(WLب:EPǗCMEW w L (|{ ՝I
m( ]G5-nhdmB b2\Wa2SDSSZ!čUBie^ 3_@[br0 G߅Oj
;g3mڭ*c
k%u#僬t¢4M
VwT#S yo&< 螯/x4Cu=>+O(?H8O,9O;HM^ |͡i\h f4hZb e. S")Ӡ:h(xčޞ0Z@6 W:ԕUj{.^#U^"-X[[DPz" qE$Q,>)ւƾ#]p-ݷҍ; > "n$P E } EGs w2}m=XO 0L.l rb6
4e-谕Qք;mqbXY!b2ieq c G.czǓZK
Zܮ.<l76/RU4e8ai qGo b:eSv
ącV;b(bR_Nm!;笤ˈi?1?d)0oe?v-C/v&ӡȗk @ KP 0+].{DOݮ>x6b!E(?<] RS{W9 /JdЍ G\g̚śd.Jƣ:V YCպ %j! ;{>(}k\sv w4DTC XTnw mPu4|^OQOJc$Ӱ@{ʕ3$UyV$[B?e'D~8V|xyT^`94^Y5Vhn'
AWM$ 7S⺯g̶^Zҵ_{m»w F'$GڸͺJHt84@qJB^Iq7Sd*aA^Icᶟzdj[¶6 I]dя9toi #$ZuEM,m}
{6W_qTlv\Aه\%1 ?Q:x` 8>'j J;⨤QZS ҝr_I:ά4n`CH,}F%IAFۣ JI=ٚ>}=~7_vW<0k X۶z0Ö~YU^
_fŭo49ͨڳ#GqOk_& @}FsyV E`e>$R{Tl+4[(p )bӉ( \Tv½OBjT|m@Ŝb+ևjDS#pT7I4
BT I5 A" vnHV=G_DEw+7?y2
IvW|:$; '? ܴHCtH=N+TJJ+H@VQfֻR?a"1V;xf7=2ִ$Q@sV"$_2_~t Vi'ObZGX*1Ȩ6ܠu'|R(; 4 e U V96:aO? d+@lh 9Ziv `28GE&(-\}t^eXFLk:JoۦD%. Z4 :ٗ VMs̲"U^ *W]v͂Jd^Ѳh<ˣk6
Ad՚&}U{OXz&f>ACOao$~O¤f,2Z6,*wm:u s4
ۤ,@ُZWaO.4]rQvڅ9E2|>\2DEtLUh 0(cSOW#i)SPyj >ƕCjd=A#| Phн_7zaZ\E'4m,8"IB îS;bL$eSz tc{hz?1j}JֹƀPB־UU2om*[h_f|Z\LLN2
,(A_M&ij7Ux^AFśTW9|2jI϶*1To lN{R 0_'yE% ¸yhocgdqW>SLlV@AE u`qKgp:|{d j4Yj|1
ʜheݸI'M.% nLM̾
?VYyLu}8HF:P2gJ=TFkJmN5Px0ъ˩])* "hVInRV mqMInI78/=G].ؒkE{q Uđ%6huY:ᄺ(ZͽE }}FxܤUGLQ
\y6牽䝱/V-đ{e+Y?f+Y@ ۾N̛aƝbȼeZ ؖkn-)~5Ɲu@&/t߉P{2 bbi JJr -D|flwBW&y)h,;xWV^к PkpNxo ''avxN o!ذFeO1ғbЭU :7Ĉ& ޏ*/*pd Y-#PyrEͽL )ݎM6jo)8_+d 0%ߒWid yqX4'r^/ t>1 !kC5 QOƣ0+LzU"p
S:vr,gE ^0xG\Xy\
&qLWC! ' \B}KR+J FYam\Nq 0/Jo^]GXזV *Zrƽ3X~\.cy<ΗYXE0DABoO|2EJbp}hpG
_Mͻ//Q> n|k/$ GYu^\#EL;*Yjw;W ^,8ZB 5
W6U-<ۀ#|#6w}GYb#$
]ZvPv 1@Gk'WN=e+.<;"Y >
;)u mʔaLj%ŵd B?,)7ʧRFXqጐ[Kd=6
x,lE{ ڞcm5q-\+2N+yz/uk_E$; aca 83Luy9M{c*/ډ)QrgkZeRepo!wެ b7߱-ġ*n- ?,CC5+ۏJ5+T-͑ T8qoЂ-bvZ᭶ 0Z6R3 [+%4jI8E._nePGJo# qKPw5["ZdV=T{S(ξ Ƣ0 ߘ,-A/ _PE#C[o쏤aEz Scj"Έi%NrF yoCQ$dwj<-
]I ;dGV㳈vXt v';_B&^ *aΝMV}MNBzGᇶ>JЭ[Q9Is
/,P"AO Ѷty<8F/gbS GhX5H.<[}XJhGZasEǧ$0Ť%)j#;FN^KS #'3JRXʟ pT0jF0l#/Ԗ;$vZgZ)B~?&瘙Z[K`{0tXBKkW'v"Ox oAh~ dKT^GdSC$l G̮˪2]HG#1^iWnm$/AgiǚR9&mjP췶#ZjdtڻB*R1 R8
)3JZO Gp1 gb+5+%3 /Xktq!y| WfmAV41%9;Ҽǣb{ U׳ w 6#"S_^[¾S kP Ҏd G2N5O[>JﮅռQJ_++P>?L^9 K0 d/>\|exznT y $vڽj?SIyUt8h"L3(t?＾O0*x GH)(C!v P$Qo4CpN W.Bծ.ňM~ GjbnYHdbK1GHm@po);wFgR*&Lsy - LR_w#jbў_OOP7 kן|<|4mt!8Oba/2u;^znsS9dkN/ )g1چzm*~H@Iޘefۓ3$kNe[6?b
x ;ViJCaFZ3ݸ
AlMzScו<臻mqQR2V2m7T 81 lmyq_N0d [$o 9TqZ
vP?^ m ɕ4܁ʌMv錖sJ`apq]LjTTlFQTC f AߘnZi|Zʃ:2gMPV8焱ZY $}kn0 ;`y*F,.odmT ;B*+1[h$2 e`p]O14q¨(@t(N`>\h: ;v>lf*ǡdQep` B
2ގ+bD;_y\H:0Ac=$|I0²
O\pjv{Jw K/" 58cz*$SO B$t(ZQ~PV 5G1E +$j)wYȂڵй5 $-;!ھ,kvpI
_~o~LP
+,[JؼZ50cnec}*li @ `ձZ}Ylː[)]W\k^~д?AFZ?9y}4{ -= [0]>y T/% C i+ `VNMG2{qJܘC] &jHUe aT
ҕt `*E|qX| +V[,?i<4*8.kz "ִ Xd|N}s](2!|S 4kMZM>!iY~>9'ng*|5 `PNNF
/|4y9E
|'pVd,|O D=GG& N恹_ +R<שϬyZZh $ё1 5ɣË 2[(~$0̞IQi;AX-?~PZJTMU pϒ4߭#5$$W0h ecOvFIIN ՔWںV@G0msAlWzLƂ 2uLJݑ,Y6BH Ūԁ)Rv]Fl t+P0=rp{PUԜ8K&?[XzJ+⭝oKk,k 7#\aylT7J;gBէ("tV+
v0*~2O21 oJ l ` 5;`Ŝ Z2 4p9A5_6jQOeHo.kK hRQq0;* Wu fO|%哨@J)XuA=GL ej+?N<+@^"Tvlw Չ} . рI*|r8P
X?،WG1~7'5IL W8K'r~@ڽ2Ql0NoBH i]_Kq3FkN>S11KM =p͚s]
*)=N۫ .Ȯƴ=j#e 0 AvBNu% A$)?d: `?UZQS^O9 H`
kZZIM, $ %'ٰT
]x0E ڎ/dm|qM/$滵FlVE* S"K.yT[T*zodMJĝ(qV{\I=-^-WhA~mZLh;en
2C38'H ?yx-?\1/(Eqx#;^)DU Ux_Bk,$W,Z& 3]7D"4: d!7j
6'#qb
tjԊI[!AUX-7ÔTk+٩aȭޥ#d UOsy?/u$ lpPvʒ5'a$I+ڸ2HA*Hj FmM@gU+?gmv8 )^RMB 54I( ,0Vj =WaZa|ЎW%6'n HeXT9ޟ \C: 07.\ $/с#I8dבN[b,Sɫ-Wm?֕h*CLޤrl 0ȴ*>x HѶA1iM2틋J'č#ħӢjo][iލ:qQѝs|7dWM$ZD["~a vN㯸=Im0hvitĿFv%ߖv욅Ńs՝-r 2XoM]2ם6GlkgId5Z knq0_zRy/I?^m-TNm~ x+:@Twƪ&(_6 BX y}Zsz5:! vrE&{٣H?O-b^d<}ܐ4T\,Y w4i2= 쬿y84f'ar#WC 0C%h=ȴ~{qt觶Jm&@ǧ\ A Pl2*#4s\mw5A2zW5 $M1.QE$] бN'|%@ FF<\5)OA&hǹ or$ܷ@hz4|->|Gz|_Wx
>mtP|0. |FC=4
QVS3*q ulJ1F
V{+fOYb%]OfNL
[D; Iao._&A%ߖ&% Zb%x . y}垲K'j#'cN9 w놚e֟){7y8\x2 i#Uu?hwGf؟* VNRe -Y[گE\&SO #q_;&jT $W(B:(! |n>xqiM ]xh3v|wQUYHUt/&qp)Ng#Ta; jךuM/KҙoӯO2joZpK1$iL2rSqVIG'; ;-:bQZ0{I^4W$2ފOo JBqt=ߍxs&( :CӾ?kr:H8۩Eʼn~[\ -PA\
$LjaE˗>I|\9U:Xj>ںm7CbV\Hq:)n(hzx5w
Y)Z}8
~kvuٔpB7.|- o&{kmN Y9O >&5
A_\3/R%z',a:%d1
\hm 3 `0@fQxFlUE:bqeFuƘ
Ҟ@ q"O]
j*`FS`i(e*҇|= U5
S`V Zҽ2jy$#e(~8Ş`8cgUɫOa̱4M5& ~^]-zc{$v< Q46(M?B4Jw%!C\/Y\j8J3fYH+ SR~G]h)
P0ߠ]r=T xCbOP S 8
NHfWY4QvFVV
LX|˧KE=
HQS5~+
Z ڱ`5ŀF #huIuw" K!ii_?:Iㄓq=<-F'
iHbrao+Q+OݯC @ clc]G\4߾9N8>K e_µŊT|'W)p,0pI 12zc@py!) .@5i)JGpڊ vi:0>M_s!~ԃE;i^X iy&Syl9S4q,rU˺?XXގctJdYH0ƇE%
hi16G y$S :B7d0Z +m̶ہL ɠ$ڴ 5g-hOKkku< _0-k;YCif wme G9ɏtMC"i@+cJ6è^2F%H`h5 'N8. ۦYm'`i1 E&ܨGQ/D_l\`⋰ʐ ]f(P[q˧ZM /j Ԩf
>C
u ZXǦ\\ O֑b=,r2#x&:_gU$R`v~ɡb\& adzn='0UX t# b1'aOqkp9oQ7L&:D/h4Y@FMq,\}re1 g:nA?
F}J8&qr? &zȤ A۶<%1X ҋ0I*/r-m-ǝY7@P2GkvmuKGFvE6NItsް|+-z |5qģ
q$vjiL*}؛*b%@cBN!s(U Vh!zU$|)_ IlNG4;ue%d ac];e=ƻt FRZx19ۊ'Dei!z
T=V=잭ԭݍj@[h@6i># nǧAaLЎWH?m9ߔ57
g-BL76ȃ*z^ׁN8Ŝe L끖Ɋ-UGlI"RL$8c0q wP0^T$!z\E /ATJSj#FT6>P5HzvC3Z(QvlGOǨK;ȟc銁E5s*yMARG8 qe\Y}d:~XUAV2N|GZFVM v^M2Uhze n68;o.Nf x%zXz\p٩nXWzT\O * 0 3zA[#w@zooJ އ"xe=Vρ O7%Q_J^cҙe~#& N<*%' "L@0;ҝ:3ߦ>,E:W|
W h>X?V&kO|JJ R~8
{`Fr ~SǮ+MNrqŀ 'Ӊ^?[[$2Jo\(xS$f_8-? qy =TZ|¿0> x'/0TSjxΩT_Z]S|$N >$~^~}C~]{xe;S?::(>ǵ(?1SlBJ" tG] AOAOC&k ?W5?
endstream
endobj
43 0 obj
<>stream
hlRkL\Uw{\J97RXX7@I ,,zfm}dc)!By)"Pl+5jZԪ%ѹu@R99sfy~mFVvFfhvĦWb!*Ր`L?o=,ZC<8
w nZU ?Z!$?V}O0F"
:U_aW v`1GɲfWbqZfZl.K$[InPLfKIrvXdcl7Gj˝VդX-Ψ8p<;9.9.9
WqΏ]!<OSLkj3fӕ]w %L DACBq @5JK=j'`tbt
ev #(,rҩ%2?ZW䡞~#pzӾ2>ܙ| x>stream
/GS1 gs
BT
/F5 1 Tf
8.9663 0 0 8.9663 62.022 435.4582 Tm
0 0 0 1 k
0 Tc
0 Tw
[(hypertension,)-293(and)-290.4(none)-294(experienced)-291.2(intraoperative)-294.7(hypoten-)]TJ
0 -1.2203 TD
[(sion)-282.9(\(SBP)]TJ
/F6 1 Tf
4.5778 0 TD
(<)Tj
/F5 1 Tf
.7208 0 TD
[(80)-169.7(mm)-279.7(Hg\).)]TJ
-4.1858 -1.2203 TD
[(The)-322.4(median)-329.4(in-hospital)-326.8(analgesic)-330.5(requirement)-328(was)-324.9(4.7)-166.3(mg)]TJ
-1.1128 -1.2266 TD
[(morphine)-480.5(equivalent.)-481.2(Eleven)-478.4(patients)-477.8(did)-477.4(not)-474.5(request)-482.3(any)]TJ
0 -1.2203 TD
[(analgesic)-229.4(and,)-223.8(more)-228.6(than)-228.1(24)-163.4(h)-224.7(after)-228.7(surgery,)-230.7(only)-222.8(two)-226.2(patients)]TJ
T*
[(asked)-412.8(for)-408.6(pain)-412.5(medication.)-414.2(The)-411(only)-412.5(postoperative)-419.5(compli-)]TJ
T*
[(cation)-337.7(was)-337.6(one)-341.2(case)-335.1(of)-338.4(pneumonia)-341.6(successfully)-345.9(treated)-339.1(with)]TJ
0 -1.2266 TD
[(antibiotics.)-366.6(The)-360.4(average)-365.1(postoperative)-368.9(hospital)-363.6(stay)-359.8(was)-362.9(3.1)]TJ
0 -1.2203 TD
[(days)-444.5(\(range)-451(25)-447.5(days\),)-447.9(and)-448.5(the)-446.4(mean)-449.3(time)-444.1(to)-452.2(resume)-443.3(oral)]TJ
T*
[(nutrition)-215.6(was)-217.4(1.2)-210.6(days)-210.6(\(range)-217(12)-213.5(days\).)-214(All)-210.8(of)-218.2(the)-212.4(patients)-218.6(left)]TJ
0 -1.2267 TD
[(the)-218.7(hospital)-224.5(with)-217.7(a)-214.5(good)-221.6(cosmetic)-219.1(appearance)-219.4(\(Fig.)-218.1(2\),)-217.9(and)-220.9(the)]TJ
0 -1.2203 TD
[(mean)-373.4(follow-up)-378.3(was)-375.5(10.5)-368.2(months)-375.6(\(range)-375.1(322)-168.8(mos\).)-378.1(During)]TJ
T*
[(the)-357.8(short-term)-361.8(follow-up,)-355.9(postoperative)-362.6(blood)-357.9(pressure)-360.6(was)]TJ
0 -1.2266 TD
[(controlled)-367.1(without)-367.7(drugs,)-367.8(and)-366.3(no)-360.2(recurrences)-373.1(or)-363.9(mortalities)]TJ
0 -1.2203 TD
[(were)-280.3(documented)-288.8(in)-278.8(any)-279.2(of)-281.5(the)-282(16)-283.6(patients.)]TJ
/F3 1 Tf
0 -2.447 TD
(Discussion)Tj
/F5 1 Tf
1.1128 -1.8273 TD
-.0215 Tc
[(Ph)-5.9(eo)-5.3(chromocytomas)-313.7(a)4.3(re)-312.3(tumo)-5.3(rs)-313.7(arising)-310.4(f)-3(rom)-309.9(b)-.6(oth)-315.7(t)3.3(h)-5.9(e)-305.9(ch)-5.9(ro)-5.3(-)]TJ
-1.1128 -1.2266 TD
-.0206 Tc
[(maf n)-517.2(c)-.9(ells)-521.4(of)-520.6(the)-520(a)-1.1(drenal)-517.3(medulla)-519.6(and)-516.8(e)-1.5(xtra-adrenal)-517.3(sites,)]TJ
0 -1.2203 TD
-.02 Tc
[(which)-390.1(p)-2.4(roduce)-392.9(and)-389.7(o)2.5(ften)-390.1(s)-2.3(e)5.4(c)-.3(ret)4.8(e)-392.9(cate)5.4(cholamines.)-396(T)2.3(hese)-386.6(vaso-)]TJ
T*
-.0226 Tc
[(a)-3.1(c)-2.9(ti)-7.2(ve)-256.4(t)-4.1(u)1.3(mor)-4.3(s)-251.5(t)-4.1(e)-3.5(nd)-253.2(t)-4.1(o)-253(be)-256.4(la)-3.1(rge)-3.5(r)-4.3(,)-253.1(w)1.1(it)-4.1(h)-253.6(p)-5(rom)-7.5(i)-.8(ne)-3.5(nt)-257(va)-3.1(scu)-5(l)-.8(a)-3.1(r)2(i)-7.2(t)2.2(y)-254.6(a)-3.1(nd)]TJ
0 -1.2266 TD
-.0193 Tc
[(pr)5.3(eoper)5.3(a).2(tive)-550.3(u)4.6(n)-3.7(c)6.7(e)-.2(rta)6.5(i)-3.9(nty)-548.5(a).2(bou)4.6(t)-550.9(ma)6.5(lignancy.)]TJ
6.7246 0 0 5.9768 235.1054 203.8676 Tm
-.0289 Tc
[(10,1)-9.4(1)]TJ
8.9663 0 0 8.9663 254.2676 199.8425 Tm
-.019 Tc
[(Pneu)4.9(mop)4.9(e).1(r-)]TJ
-21.441 -1.2203 TD
-.0216 Tc
[(iton)-6(eum)-183.6(a)-2.1(nd)-189(tumor)-186.7(m)-.2(anipul)-6.2(atio)-5.4(n)-183.1(c)]TJ
14.5553 0 TD
-.0205 Tc
[(ause)-184.8(excessive)-184.8(c)5.5(atecholamine)]TJ
-14.5553 -1.2203 TD
[(release,)-307.9(which)-314.7(m).9(ay)-309.4(cause)-311.2(f)-2(urther)-312.1(intraoperati)-5.1(ve)-311.2(cardiovascular)]TJ
0 -1.2266 TD
-.021 Tc
[(in)-5.4(stability.)]TJ
6.7246 0 0 5.9768 101.1401 170.9858 Tm
-.0279 Tc
(12)Tj
8.9663 0 0 8.9663 111.1748 166.9606 Tm
-.0208 Tc
[(B)-4.8(a)5(sed)-409.5(o)1.7(n)-416.2(t)-2.3(hese)-412.7(co)-4.6(mplex)-415(c)-1.1(linical)-410(features,)-409.4(l)-5.4(aparo)-4.6(-)]TJ
-5.482 -1.2203 TD
-.0178 Tc
[(sco)4.7(p)6.1(ic)-459.7(ad)4.5(ren)4.1(a)1.7(l)4(e)1.3(ct)7(om)3.6(y)-464.8(f)7(or)-461.1(ph)4.1(eo)4.7(ch)4.1(ro)4.7(m)3.6(o)-1.6(c)8.2(y)3.1(tom)3.6(a)-459.9(wa)8(s)-468(o)4.7(nc)8.2(e)-466.6(c)1.9(o)4.7(n)-2.2(-)]TJ
T*
.2623 Tc
[(s)280(i)284.1(d)284.6(e)281.4(r)286.9(e)281.4(dr)286.9(i)277.7(s)286.3(k)283.2(y)5(a)281.8(n)284.2(dw)286(a)281.8(s)1.7(p)286.2(e)281.4(r)280.6(f)280.8(o)284.8(r)280.6(m)283.7(e)287.7(dw)286(i)277.7(t)287.1(hc)282(a)288.1(u)279.9(t)280.8(i)284.1(o)284.8(n)284.2(.)]TJ
6.7246 0 0 5.9768 240.0944 149.0456 Tm
-.0285 Tc
(13,14)Tj
8.9663 0 0 8.9663 72 134.0787 Tm
0 Tc
[(In)-460.8(recent)-458.9(years,)-464(advances)-461.9(in)-462.2(preoperative)-466.1(medical)-461.6(man-)]TJ
-1.1128 -1.2203 TD
[(agement)-346.6(and)-341(improvements)-350.6(in)-342(surgical)-348.8(and)-341(anesthetic)-352.6(tech-)]TJ
T*
[(niques)-203.6(have)-199.5(resulted)-199.9(in)-196.6(widespread)-203.5(use)-198.6(of)-199.2(this)-204.7(procedure.)]TJ
6.7246 0 0 5.9768 284.3149 116.1638 Tm
(1518)Tj
8.9663 0 0 8.9663 62.022 101.2535 Tm
[(Some)-504.6(investigators)-502.6(have)-503(even)-503.4(suggested)-509.3(that)-503.3(laparoscopy)]TJ
0 -1.2266 TD
[(should)-470.6(be)-465.9(considered)-472(the)-471.6(gold)-469(standard)-466.2(of)-471.1(care)-467.3(for)-465.5(pheo-)]TJ
0 -1.2203 TD
(chromocytoma.)Tj
6.7246 0 0 5.9768 123.307 83.2819 Tm
(19)Tj
8.9663 0 0 8.9663 72 68.3716 Tm
[(Recently,)-340.5(LESS,)-334.7(a)-334.6(new)-340(alternative)-340.4(to)-338.4(conventional)-338.8(laparo-)]TJ
-1.1128 -1.2266 TD
[(scopic)-405.9(surgery,)-401.4(has)-402.6(been)-405.9(performed)-404.7(successfully)-402.8(in)-405.3(various)]TJ
27.9978 74.5471 TD
[(urologic)-366.1(procedures.)-367.3(Compared)-365.4(with)-363.1(standard)-365(laparoscopic)]TJ
0 -1.2203 TD
[(surgery,)-477.3(its)-473.2(advantage)-472(lies)-469.8(in)-474.8(consolidating)-473.5(multiple)-479.1(ports)]TJ
0 -1.2266 TD
[(within)-243.6(a)-239.8(single)-237.4(skin)-240.3(incision)-242(to)-237.2(enhance)-242.7(the)-244(cosmetic)-238.1(outcome)]TJ
0 -1.2203 TD
[(and)-296.8(minimize)-293.1(the)-288.3(potential)-299.5(morbidity)-292.3(associated)-295.1(with)-293.5(multi-)]TJ
T*
[(ple)-548.6(incisions.)]TJ
6.7246 0 0 5.9768 366.3495 685.9274 Tm
(20,21)Tj
8.9663 0 0 8.9663 386.4188 681.9589 Tm
[(LESS)-546.7(adrenalectomy)-551.4(for)-547.7(pheochromocy-)]TJ
-8.1819 -1.2266 TD
[(toma,)-186.6(however,)-195.3(is)-181.9(still)-189.4(an)-186.3(infrequently)-189.9(described)-192.1(technique.)-189.3(To)]TJ
0 -1.2203 TD
[(our)-207.2(knowledge,)-209.2(our)-207.2(study)-212.9(is)-207.2(the)-206.1(largest)-205.9(reported)-211.1(series)-209(to)-205.6(date)]TJ
T*
[(from)-286(a)-277.7(single)-281.7(institution.)]TJ
1.1128 -1.2266 TD
[(According)-188.5(to)-180.3(the)-187.1(few)-185.4(published)-179.9(studies,)-190.8(almost)-182.2(all)-183.6(surgeons)]TJ
-1.1128 -1.2203 TD
[(reported)-489.3(LESS)-483.5(adrenalectomies)-488.5(only)-482(for)-484.5(benign)-480.6(pheochro-)]TJ
T*
[(mocytomas)-302.9(con ned)-299.3(to)-294.1(the)-300.9(adrenal)-300.4(gland)-292.1(and)-303.1(without)-298.2(inva-)]TJ
T*
[(sion)-295.5(of)-287.8(adjacent)-288.2(structures.)-294.3(Interestingly,)-296(no)-290.7(consensus)-292.2(exists)]TJ
0 -1.2266 TD
[(regarding)-367.3(the)-357.8(recommended)-367.4(size)-358.3(of)-363.7(pheochromocytoma)-365.7(for)]TJ
0 -1.2203 TD
[(LESS)-287.5(adrenalectomy.)]TJ
1.1128 -1.2203 TD
[(Most)-186.7(in)12.1(vest)16.5(iga)17.8(tors)-182.3(have)-186.9(pe)11.4(rf)11.5(orm)11.6(ed)-192.6(LE)13(SS)-193(adr)15.8(enal)19(ect)13(omy)-188.1(for)]TJ
-1.1128 -1.2266 TD
[(pheo)11.6(chr)15.6(om)12.3(ocy)12.5(tom)11.8(as)-418.1(of)-414.2(sma)14.3(lle)12(r)-424.3(siz)14.6(es)11.4(;)-426.5(h)0(o)12.8(weve)16.8(r,)-414.6(Chun)17(g)-421.7(and)]TJ
0 -1.2203 TD
[(asso)14.1(cia)16.6(tes)]TJ
6.7246 0 0 5.9768 351.2125 554.3998 Tm
(3)Tj
8.9663 0 0 8.9663 358.2424 550.4313 Tm
[(re)12.1(cent)15.9(ly)-400(repo)14.2(rt)11.5(ed)-401.2(two)-403.2(LE)13(SS)-408(re)12.1(tr)11.5(oper)14.2(ito)12.2(neo)12.9(sc)12(opi)11.3(c)]TJ
-5.0394 -1.2203 TD
[(adre)15.9(nal)12.5(ec)13.5(tom)11.8(ies)-390.4(in)-386.3(pat)11.3(ien)12.2(ts)-387.5(wit)13.3(h)-395.4(pheo)17.9(chro)12.8(mo)12.3(cyt)14.8(oma)12.8(s)-393.3(mor)11.6(e)]TJ
0 -1.2266 TD
[(than)-354.5(6)-163.9(cm.)-360.2(Al)14(tho)12.3(ugh)-356.9(the)-364.2(two)-359(ca)13.9(ses)-362.9(wer)16.7(e)-366.6(com)13(ple)14.2(ted)-357.4(wit)13.3(hou)11.5(t)]TJ
0 -1.2203 TD
[(conv)12.8(er)12(sio)11.3(n,)-284.5(the)-282(sur)15.6(geo)11.9(ns)-289.2(re)12(qui)16(red)-281.8(a)-290.4(thi)11.6(rd)-281.9(inst)16.6(rum)13(ent)-282(for)-282.1(kid)14.3(-)]TJ
T*
[(ney)-311.2(re)12(tra)12(cti)15.7(on)-316(be)14.7(cau)12.5(se)-311(of)-313.1(tigh)19.8(t)-316.6(adh)13.1(es)11.4(ions)-308.2(of)-306.7(the)-307.2(tum)13.3(or)-313.3(to)-313.1(the)]TJ
T*
[(peri)13.5(phe)14.3(ra)12.4(l)-484.1(tis)13.7(sues)-471.8(and)-473.8(a)-486.4(blo)14.6(ody)-471.8(oper)14.2(at)12.7(ive)-478.4( el)12.5(d.)-473.8(The)12.7(ref)11.6(ore)15.6(,)]TJ
0 -1.2266 TD
[(long)17.5(er)-506.4(oper)14.2(at)12.7(ive)-503.7(time)17.5(s)-513.5(\()0(1)12.7(9)0(0)-504.9(min)14.5(ute)10.9(s)-513.5(and)-499.1(23)13.6(7)-511.7(min)14.5(ute)10.9(s,)-503.7(re-)]TJ
0 -1.2203 TD
[(spec)17.1(tive)14.3(ly\))-375.1(were)-375.2(nee)15.8(ded)13.1(.)-388.6(F)0(u)13.2(rthe)14.5(rmo)11.6(re)12(,)-388.6(len)18.5(gthe)17.1(ning)-375.1(the)-376.8(inc)12.8(i-)]TJ
T*
[(sio)11.3(n)-389.1(for)-383.3(ult)13.6(ima)18.4(te)-386.1(spec)17.1(ime)11.7(n)-389.1(extr)15.7(ac)13.9(tio)12.2(n)-389.1(may)-380.9(hav)15.3(e)-391.9(d)0(i)12.4(mini)17.3(she)14.4(d)]TJ
0 -1.2266 TD
[(the)-269.3(usu)14.9(al)-274.9(exc)17.6(ell)12(ent)-269.3(cos)15.6(met)14.7(ic)-274.7(out)14.4(com)13(es)-266.8(of)-275.1(sin)17.1(gle-)17(por)14.1(t)-278.7(sur)15.6(ger)14(y.)]TJ
1.1128 -1.2203 TD
[(We)-353(suggest)-354.6(that)-357.9(LESS)-350.7(adrenalectomies)-362(should)-350.5(be)-358.4(consid-)]TJ
-1.1128 -1.2203 TD
[(ered)-212.2(for)-212.6(management)-214.3(of)-205.6(pheochromocytomas)-221.6(less)-208.4(than)-209.1(4.0)-166.3(cm)]TJ
0 -1.2266 TD
[(in)-215.6(diameter)-213.2(for)-212.6(the)-212.4(following)-215.7(reasons:)-214.1(First,)-209.4(the)-218.7(larger)-211.1(the)-212.4(size,)]TJ
0 -1.2203 TD
[(the)-383.1(more)-380.3(prominent)-386.1(the)-376.8(vascularity,)-384(the)-383.1(higher)-382.1(malignancy)]TJ
T*
[(potential,)-308.7(and)-303.1(the)-300.9(higher)-299.9(the)-307.3(risk)-300.8(and)-303.1(dif culty)-303.6(of)-300.4(the)-300.9(proce-)]TJ
0 -1.2266 TD
(dure.)Tj
6.7246 0 0 5.9768 333.6944 390.0471 Tm
(22,23)Tj
8.9663 0 0 8.9663 353.9338 386.0219 Tm
[(Choosing)-571.8(smaller-sized)-570.2(pheochromocytomas)-569.3(for)]TJ
-4.5588 -1.2203 TD
[(LESS)-382.3(adrenalectomies)-381(in)-373.6(the)-376.8(early)-381.1(phases)-373.5(of)-376.3(the)-383.1(use)-375.6(of)-376.3(this)]TJ
T*
[(procedure)-312.5(follows)-313.2(the)-313.6(principles)-308.8(of)-313.1(putting)-312.2(ease)-304.1(before)-311.7(dif -)]TJ
T*
[(culty,)-283.9(thus)-284.7(ensuring)-283.6(the)-282(safety)-284.3(and)-277.8(ef cacy)-284.1(of)-281.4(the)-282(procedure.)]TJ
1.1128 -1.2266 TD
[(Second,)-1046.7(after)-1038(attempting)-1048(to)-1040.2(perform)-1040.4(LESS)-1039.9(retro-)]TJ
-1.1128 -1.2203 TD
[(peritoneoscopic)-306.9(adrenalectomies)-298.8(for)-301.1(adrenal)-300.4(tumors)-295(of)-300.4(vary-)]TJ
T*
[(ing)-257.9(diameters,)-261.7(we)-254.4(found)-263.9(that)-256.8(adrenal)-256.1(tumors)-263.4(less)-259(than)-253.4(4.0)-166.3(cm)]TJ
0 -1.2266 TD
[(in)-430.6(diameter)-421.9(can)-425.8(be)-427.9(completely)-423.7(removed)-428.2(from)-425.1(a)-423.1(2.53.0-cm)]TJ
0 -1.2203 TD
[(incision)-343.2(without)-336.1(incision)-336.9(extension)-339.3(or)-338.6(morcellation,)-336(thus)-335.3(en-)]TJ
T*
[(suring)-457.3(the)-459(cosmetic)-453(advantage)-459.4(of)-452.2(single-port)-458.1(surgery.)-458.3(Our)]TJ
0 -1.2266 TD
[(results)-362.7(also)-354.9(demonstrated)-353.4(that)-357.9(LESS)-357.1(retroperitoneal)-361(adrena-)]TJ
0 -1.2203 TD
[(lectomies)-286.5(for)-282.2(pheochromocytomas)-291.1(less)-277.9(than)-285(4.0)-166.3(cm)-281.4(in)-278.8(diame-)]TJ
T*
[(ter)-475.3(can)-470.1(be)-472.2(completed)-469.4(successfully)-478.6(in)-468.5(less)-467.6(time)-475.7(without)-468.9(an)]TJ
T*
[(additional)-287.8(trocar)-281.6(or)-281.7(lengthening)-282.6(the)-282(incision.)]TJ
1.1128 -1.2266 TD
[(Most)-351.1(surgeons)-350.3(prefer)-344.5(transumbilical)-350.4(LESS)-350.7(adrenalectomy)]TJ
-1.1128 -1.2203 TD
[(over)-522.6(the)-522.2(retroperitoneal)-525.4(approach.)-523(The)-518.4(transumbilical)-521.2(ap-)]TJ
T*
[(proach)-430.6(has)-427.8(the)-427.4(bene t)-428.4(of)-426.9(a)-423.1(better)-429.5(cosmetic)-427.8(outcome,)-430.7(more)]TJ
0 -1.2267 TD
[(ample)-235.8(working)-242.2(space,)-231.9(and)-239.8(earlier)-235.4(ligation)-236.1(of)-237.2(the)-237.7(adrenal)-230.9(vein.)]TJ
0 -1.2203 TD
[(Intraperitoneal)-375.3(organ)-364.9(retraction)-371.1(and)-366.3(mobilization,)-368.9(however,)]TJ
T*
[(are)-240.4(usually)-230(necessary)-237.4(in)-234.5(transperitoneal)-241.7(LESS)-236.9(adrenalectomy,)]TJ
0 -1.2266 TD
[(which)-340(are)-341.5(troublesome)-343.5(and)-334.7(time-consuming)-341.4(and)-341(may)-336.6(cause)]TJ
0 -1.2203 TD
[(trauma)-283.6(to)-281.5(the)-282(intraperitoneal)-288.2(organs.)]TJ
1.1128 -1.2203 TD
[(In)-397.5(contrast)-393.6(to)-395.3(the)-395.8(transumbilical)-394.7(approach,)-396.5(the)-395.8(retroperi-)]TJ
-1.1128 -1.2266 TD
[(toneal)-319.4(approach)-317.7(allows)-315.8(for)-320.1(less)-315.9(invasiveness,)-318.7(because)-315.5(it)-313.8(pro-)]TJ
0 -1.2203 TD
[(vides)-217.1(more)-215.9(direct)-215.5(access)-215.6(to)-211.9(the)-218.7(retroperitoneal)-215.6(organs)-220.8(without)]TJ
T*
[(maneuvering)-216.7(in)-215.6(the)-212.4(peritoneal)-211.1(space.)-212.9(The)-214.9(major)-207.8(disadvantage)]TJ
T*
[(of)-281.4(the)-282(retroperitoneal)-291.5(approach)-279.8(is)-283.1(the)-275.6(limited)-283.4(working)-280.1(space.)]TJ
0 -1.2266 TD
[(In)-315.3(our)-314.7(cases,)-307.7(dissecting)-317.3(and)-309.4(removing)-316.5(some)-311.4(of)-313.1(the)-313.6(retroperi-)]TJ
0 -1.2203 TD
[(toneal)-230.9(fat)-234.4(and)-227.2(adjacent)-231.3(tissues)-230.5(outside)-227.3(of)-230.9(the)-231.4(Gerota)-229.7(fascia)-231.3(not)]TJ
T*
[(only)-374.5(provided)-375.4(a)-372.6(larger)-369.2(working)-374.9(space)-374.4(but)-366.6(also)-373.9(reduced)-373.9(the)]TJ
0 -1.2267 TD
[(potential)-451.2(damage)-446.5(because)-448.3(fat)-449.4(interference)-454.1(in)-443.2(the)-452.7(operation)]TJ
ET
q
1 i
62.759 732.245 m
300.416 732.245 l
300.416 496.006 l
62.759 496.006 l
W n
q
237.657 0 0 236.239 62.759 496.006 cm
/Im2 Do
Q
Q
BT
/F7 1 Tf
8.9663 0 0 8.9663 62.022 479.2251 Tm
[(FIG.)-501.2(2.)]TJ
/F5 1 Tf
4.2553 0 TD
[(The)-499.5(surgical)-500.5(scar)-500.3(of)-496.4(a)-499(41-year-old)-500.7(man)-493.7(on)-499.3(post-)]TJ
-4.2553 -1.1065 TD
[(operative)-337.7(day)-335.7(30.)]TJ
/F3 1 Tf
0 31.2668 TD
(58)Tj
49.7234 0 TD
[(HE)-329.5(ET)-338.7(AL.)]TJ
ET
endstream
endobj
48 0 obj
<>stream
Adobe d C
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? rBo NS; C\6WB n*
{7H'.#ۿ D
u; Wj˭O
zuQпZ_bqj@ ,Y$SlzJyю'Bvas)"ߐ 3z N= tAF$^
`Q̝56GmsV ~brZ?!nyY2X Zbf &(a'z
mZ15 j #pz51\]ܣ=̚TH;SC)Td~v sQv%?~)(5Y7YH8. R@9
qOP'N9oP .'o p~%G"!'buě7Nw
)q6@+qڹ?
|wNING6[A-p> H_`6 @㊄ݾXQNT ,GP)ft~E*72y( ⋮(vR^7/
>u8#Ocm
nOo?c
O1f`s-Liy uHWPO\sf -C JR5&H# "Ɔܘ21,rX[6G ar( {dw0..zmƫHlao42az@t="
jpdRJF$P']+2i}z%[1i&@à'
nm.GF; -̚:z8OIWH|pDqS#JuF*+@+ ],
7R)҄+Gߗ_& 5 ;t˩NDr4݁jcHcJ8+I~9em^ƙDm@ փƽ)%=*+XmjcZ 6ƘjMރČ Mۉc\-b bOG7YH`FĮͻESm-E8##oZ^I7V-gb=CS}D˸q}sG.Q4!^
rSanJFDZ@0- ( XcԜJ# ~ }h[=hzJ jC4qɜ{dW3q6l]9 #b穡pV!~F4_}p^4!F/SѨœQ+U5L,:^RH㊮(k* SB(e
& GŶ`nw̡e~v¾ٍ>Ҕ< S@>($2PPP@m>!_
='f26&SG#^ĥXR pv;2urkZ=W3i1 00-
jGDՔv86JH /FXY~V %? >0 dnHC{^E'g!*w;W!svjh"ɦoտ_WA7k* OF>8O{uzӰraGDu4pWv9qaⰦWq -[
F **DwݻPi*jwP{^{+PXoܝճ
nO,T 9E
_ ~L(½l}9j:W7 }WcV5w+pv=szx7]5'4N'[PGA~m5{4__Uĝqm3Wf{zQ{z^kYB \Pޣ$S>oo2`NOO 11x=~BhѥG Ҟ8\KA@:tH@h[ۯ؏}sM, z rƺ=Nj=HW-v
i)+?=_R8mgLVbт(p\G|^3
SaFN!xYv8S|p *PF8F_#cFnMZRNf5}56;mrM&;נPGZSj-tGC:)=6;n=c$CtT0
B1540 I=0-ƞ\؞qT uu-ű #ЏNtba!el[H +ae*ƛ5kX G{a P7n\DS{bamgmBh}Otd~0(P
uo!N6
@x' F}L|ţb[aSþ,Eʣn.> 1tc"
}d1 qHؠ& ߧ.S}:ʽ1vIr7'dPC)ic([sLH)cY7ё FT~`:4z*Ԓկ|cP;e6 q:Ƶ
}P$(O|Hn6$
kj U~{)f%q/b7aNէ\ڢ% >#0eu $nc?ݟ_
j,qK8AEؔ5ӂoXE N*|pY#uijtaaJmp'`8E#y6OaoVi?q8Fwţ&!aƽ
sC]}Bb6,ڿN=:МUW~Oᖼ 'ُjU"qāEˡsA#c _;S vlrAeM|a$<2 2mc\
+Rm(e+5mzSQj@M17jN6ċ@zYS=p0jqїb0^yԡ sZGsnn,EpNg6WZt@a95c파z
3} ėfbqDxZcB
tLkn} :Rx}̹=OSEqOB+LZ0*}xȨI_ LFlWCM|^#\^W'U LV0K$ hiQcs^c{[Gӈ5$Ęu =8S|
Vtm*G)j`uέWgTݩ j;}
6(w2U 80 -c=E=T㦲)Jm.L/^Jeވv3 qҘ `A{`G m#ރ @㋢P%Tx@A~qN*?^)V$1@fSnk@Nj:
CO|PR WqNBw4 Mj;e< w Jlqv Ao|(t5ޘ¤P6m(k%v*=cLe6lOLk:qMx .BMFlr|+= y>oƌqm_5=}I({dO!#G4{nܱ B(*p+4 1 zmO*FEӶ BAlmda˯т#]0Lf
1Ǹ)T~8nqU (*qT$9u-%yT
n2Q~}6 r/ۭq5'9JC/cqƝcUjM>P}M ^ݱW e1 H&Lm c D)(GƐ;_5؋ALfmJbd݈H{b`is{ *o{Σa|fѢZ ,yؿ!$Hz Ka:{~Sj (K[g1Y=>|##MAj;_D,K:t
#pBI7b^2.{W
|B 5=T n*ŀ icjh>|z
8;!j
M1Hl=O )htEaWV ݷl-MEȍ>
Q#7cFhm&6pB_hl~cv;
Fvg2$Pu{jMh0"`` C\\
Jz
ਆF(*/'JLzw k.vq_c:n\^* l{ OnBieI/-
eVڝS-iCOܚOo\kTv=ZS;LMI0H16R
G_ c0@?}q|Se5 s_ + j "b.v½G퓿BF緬4#x'Ss6; %p8
b
C;b1 jZ'#ӫP <6ē CF AU~X. t?_DozSz5. éǪo#P
~إ =?8(5#jc*6qO|sVtԓ-WƅҦ)^ +n_`s:=
;M7>9F5:bfvĊ4m]
h02fn?# >ۜa4t8
mLabz$bhwdL#|a=@8^h eB$Lf`\6fl3:lZ{u 8ޛ7+ǿ7UT^_j=$_MI)]FelJ:`. JSNp\Dтޞ>
%>Xdh.6jt@(EiOɱ<2=E*zN~g1of!O= b1=)aIj kMz_3[cޕхZl3V! [N߯%SPNo!LR1OLt+A@1SC58V[7A
abpIK^R=y`T Jb낢;b
pL[S6 9 qtQO|pCZزFk_ 0B~T܂+(zb7H 8\p47҈~ +:c>0| tq/R:Lxw4k T=' ֻWƕ\l5퉱]~X &hGE'O $ ǀ1(q#~\*)0]LJ9۶<ߨ \{xw˩Potr>x! k #]v8N"&Nv$ c/lBYxk|Ibܾx04 ̠wWmǮSm|Izc kO_ ?CoP~9'?9΅t.4e[0Z @CZRc'O ww ? g:֟p-%+)゠ 0 Vȉ*:狢ŗoZ!O` w*Uc) [ _ ߎznr+\Q+i+,X:z E7ğ@zoֿ(Ӱy 9q
*jv1.Fn j܂}v)
CV'p$^
Wr99k?g]T ]
k>41ܲG
m% cv~xOJJZqEYTn:>2@>n^F=K\]L]:킡 l>/l iTIߩT|JToFզu1ԁ Z0@ژ^إ*v ۠ PVZnZn`IqMŹ{ t6ā QӿLmNqh6?,ME/b mN|W|AbGcV51Ȩ b2Ep<爝q&,78c}ISq'o JG:`i$48WY W:br7n`y^O~W< n}D2i)u ?[oEq9=L\S\Nqu
q?eM>Yn?crJ;t:`
@:ڽazm#\ vx.0hpZ- @z*PU=(SS|R5 WǮ-t֙j>b(7P : N;} N`[:78 2?^2^>zP
U^Em Ev 7#A|Dx$IMv#q)X|,C `w}3?%[lL\@ (b/B~X N&&^ "OvL?-~FmPj>yH%0G أNfU?mAJ˟x]i],Fڝ_6
s9s.Q `u0dh<6J 0DJj)Q@^mc[q:HH`i?V mcATEga8+l/NJ -HfƴcQrlƿ<0=}0FO+d1XH'=a}=r'S|r5;}|4Z4 #U7ssl@aCT9d+
rci퉰5"M+;P0;Sa_HwJP pAp4zp) 1/|;Hފ~eӽ=M1~tg&;}qO|ϙ e票4$2}1@¸C) }焞eԴ ⋂#Pm|׆[q0.
L`_lS
`ߋ*GW&1@A'}Er6W00~; uqA5*Mvn,PMt
hh|1T;j{P֤tb
oö0'b(qi<1"zj
P~`b.*v4H4&;`Iڝ0)sS 1n8c #ursmmb& #AQh6$r]{_ d`4d b5Dsx> 龘23Ŭ
S) ꖗ 4 * k\X ^*$ o7c% w %S8ENsV&N*>**VgiN[qb*6ݼ\7^ Tjb54那$1*P1x(hviVĽI WՙYڻb?
cd-f+]Lp ݖj:vI hWjecYS$ ;Eڽ6W|k }8 G( &$ 17`7zl+ Fs
^Ro !Ӱ0uƖU&@SL_prk & ᨧ:G R cmkX}/y? ܩj՞~jyKXgg?_g ]]5$zjw$1mVN"3qV`cAv(F x _}+ol+Mbi1xM1FZ:W0" б6~YOU٩
{qrCIۮ=.r
qd #o~rR0ʇن>
ٮX*8r+OŁB& EB۾4)-ACAvh414% W6.jG|BV$o?*`+ߥp z`I
ۦ(Vq >Acjn gXAoawzcY*x緰Wp '' f487!`>קCU ki\JMK+Ӯ5Pp^o
H(þ
] 놖9PQAL^-ŐWíqtP틪PzHRtJ|u^ACC y0Z4Ԓ8R|09s|?
Mq&n}3`MH5@| *ne5@ lw7 1 _# >7W;$ڛ}ت#s /N5Ƴ7;8M|r; kF8 nb:"ִ֘
!` 8LUz|HhӔv?`i? [/k f Nu~&Cl
rH8PKr@f;p;lpx֔DNfPMwB;cD
A86:c%Jo 4:֦ a$W1`v ~/j
e?Ѿ=I;,Tb :#*M(}63 (egSL QP
ӁnuY-pB# H&@N?M6:PnjluE ">= rJ6v㢑Yjw
hHq(ޛ qJw 6鈸b꽱'E vI `y*ƿE1$m Ͼ݆|3W0 4)=FƟ =);`w54Z?*utP߯ߖ@z/0M x?+m9 ڟ'8GmlJf {m
E29únH;evZ0jP{wŔ#JA]}+ t=Iw;ݷ# :
L ?;kc%s5Z p;82@$xAb曈GqRBZ&ުY~I*~픯Н$m@P: TPIm= I Б.wRW4e=wSH8+ 2 ЁJP+Lg.+ҝ P݇]*m+83]z:=0bC)ʝĐ70zlư#yHܜ9l4οin-v(Z|=ZGk~yބyH
w{Xԉ_Phoܹr G#6
6}ɩǺW$ SF*K
/8"a
1cVͶ fq;Njw*Zq- &E#qWqE%O {4ށ(بDj |iq^5V;yr/ lmd}EO}"k*ͧBcK6-ߑGgLZi 1e1()c7`@
۱L+ |0 Ѓ SS\ PӮ V^_ˈ@ZV8cSlH5ۭ0,N{U< gF6Q|zf#='[y ;;c-:]Xmդt=_:4&;B:Hzd3S637
h$W08rbW
~C=rM hśmvQ/EX5Y}UUgb$z 她Hh:^M^>P~o>aZڲ<*GqUBlsW*8
)*Ȃh6>xnGJ1>bB@GѾ' ֻƪ*TAf g;sш0'J l-~~W$?(z z
kIB L /J>Y e<_#*L !ֻt_nKװ4>xZȎJco RS\5 {5PG=N:hݚ5FV@0H< pDhEIڸfƲV 7 +@wq#*ƣbO~*{;hKR:
*T][<
)EP>]tq/% 61h;
5[oPLjz |đ
TW0ejǐ\rFǜ|)]F:o}2rNn^w$r Bup'LG"rN > 3/*;rP֦ b{YeI*OWHM)NǶ'0MV~tlQSƆ)BF1 >I7*l{m'!&dHQ6 "EH߱$~
Up bShEN;lq7`I`IA25 F G|x`rS$Fx)7lt Nw\X vY
Ȅu :~LG_댷Fi
FUC?b$5h{/" FQVn m.hIZ#~ Fڵ؊Sa^o\X,ߜ\)5|JA |>d:&ڐk([PO- yiHd2O*Mz֝N2_Tс=I_t汱.RsZGK6Lt!hѭi_mc^K!$~0أ:5cNPg._.P@ [|i H Pa
OhNb2ȡm bF "SV|
0!2x q9$`+$$#71Xya
〶)QASnւf P_f g#+=sqmcw|p; ,Q^D#7@o `7rH〧\]7w
TJqH߾g
HϵJ\ΧZS5_,Q0ke
vۡ 8*cP V$U kL%`G}@;_,kk\ Bz"8RJ/ z<)S R[ '$@I5<v[S'Vn Z78"{yKe!S&NDan A@CВW
*e(#AEy}3zc~4>ئt 8SH
~57Ewap ]JH㑞Pynj7^b>g.g
~?QzQJy'9#Fa ,:u6Qo]0?2ێ;v 3V&&T{b,O"7L* E
']`HLT \^d9S^\G|o]Xn1 $6tآX
5pAM2/vޣ>(LQHw{zt >S~dcS?9: [Wj ت
>^29Ϳ^}SOr.i̎N!>KUz@` ۮ,FiZ߶HP i(? boH$ 9VM}:I j$n튬RB~цA5
S僭ğYFnAD1 qo%*\-RN /VoRJ;};[r
#w'w=\ r3l Р Oòzg* a%бzRy7_ l:߳Շ; 8u JV-31b;W
&5kn
:NltSN&}G ?w QvZޕL-TUHsL
N$n(z}9 GLO& W5'oJ$ a0>#Q$l^^jM, L
)
n&'8
J('N+Nc,0>zj+
)aUXh;amOI2iTΣ~9>Zlrra_8
~g H~xSc:mC1jPoqu$PmJ
)]Q*GqAj)aʩ#ۖ(*֛N1#ep aw 1u{`,$7`; }>
zefF
6+ƻE R!QREj=?[+ `W#qCV= LjMa 4zj: WZ ߒ2
а7:~8 J\A-V ~HXJ5ar2mFBV";sV jo@Rr1G$
q5 ~I
RElhe}:Jc%4HV& rI$zSP(USyFA1rOo|2S&> )oJq7Vzx Пj`nBm|
I?I`NJS ˾ Lvz '1ѱ0DZDi)>5q$~☺hr]TRn&|1U QFB
SƗ*TH`$*S0DvrrU"٥)n#S |`Pġ X2LPy
$n
APЧ .Ȑ"6T*ǃ~ loY-»#B]N-Z`1_W(J 9uH y*ؑpٺeRCJ){{SP 5`z jnj`y+\6>MCa_ W]~rFdn+.iЖ\9q#
j`ٲf͈A m 8> jOPxaa ʤWol{FuEۂ(
PIJ
SsGXC|DִpCJI}F+˭y~# 嚍_l}Q᪭J#qAQT O M"#p U;: ̅;|F# ؾTO3\
#q2Bޛ)AТ.z"*V|p?h F&)CQv$W; |
6
,
҄hܱoUU(8ClZPaM{Tmn9t}H Ҡ,1ۉ54,L`x Iv] ;Rg %D,ǩ8ï H;
F*iCA.Ҋ)SF]#Q%E1 qe4 1Bi)PJ )n?\G4 Y#B:> Ū*qǖalēҝyl)`f""ߦ@w8gm([ڀ\PUEN
]H4"&!h[E-'^ŢbAS`9+NfDZ_Ux E7(P_Bf_(|
}ؤ܀}Tߋpi@2Vc)oMcyWp@ u OjqhQ )tˌ"1ʁfhׁJ0A`
$Ռi i>uuuℬfQ_A ƽs4lB#aI5$ֽ8]/SZSPC߈H
q$p~x"Zu(g5mLXjaukQ& ¦zb*w V3r֝Z&fJ e*vܜY8~*U2HI b)N%f)%|^ۦ@P Zנ2/#@ SaP&8iHSM
hZb@|ݫCMVaCRJ!B>TŒ$- > 5sE;5?Aˎ3Wp>x Bej>8B+)F/ -ܨ:U1U1"{ a( eJQ#sLMJe$l)ZV+ʅh~
} QZ:{n~l:B1ɶu*r)nM^K f/[zN_#3$4ŀ覝( 8V֫_ H'|.Nn +SL cj`e Ҧe =q0נ遦$
'|/NUu!vhPHH,~ C˹;u' {,b
끳f͗Jqc{ |pt3r Rt;PZăR:~D{ M
všdԝ!@
Aط0R~\2P6 BlV h#QJ\xHcPr0rӶIǩF$+]OLVQ>BE]onؼVT EHV+P{o
M:T
AC[ ⶌ$@ ,>j0+,UB ;Tu;ce߸(剺-~!#͐۹#)^T
ęSr8x5, ir (e`)<~Ut18W3(`@1n)c}9_uw[0 =r'-SlIA#+! QBz, ) t=1hPjIUFRA<>GLO kڻ rۆlY`% Nz*Fr 0ֽ|qq% 5$
@ARGD/"pS0̒CP(A %zbs+2Ӯ4 `U ` ^@re
5f=&%ֿ*z@6)J+[P01~?ii^ ;ҽ\ ?oLGO|!hkNv@P n:8 ʑqnv¹X! ׃1N153W|O+.lAN4c` ax`4QO j7plJ; >8&@MEwQ$n+Us56ت>Hz) PqCO|Wd>2⧾( E:MG d@O961w@R0z.㋧(T|a&&
vcBIj߉zd%? Z Nܜ},Ge$tb %J|H8US[+S!'Z3RpYw {c*VM;
SA$Vq ME)%FUkM~.
*kױVF2qLs'@p4P \Տ@0Zn1/j2=2rrWLG6Uj ƣMq*h | mn#$'s0P ᅺYWUXEF 3
qN+
n ";R*y/P;`HP,j L sD{@^;qNL"9>۵G\Qc/E o|w7ܒM
qHE"m ~E/B 97"Rzͻ""kʀUA;brVeeS#ѸREvpը4 뉣H?@H GsX ݶw5)ҽb2 FáHv4ĝjL:Ta}ݹE(0(S &(*w8*ؑӃs늢8*%]bȀ"S
Tw8N1x `SCQcOS
jة֕8eCQ# YlFj8]*/31A)qNhJ|BƢ9FF#P~17ĄB_W985PF1aUcjOщW_|H Sm|
XSþ!,L {`78Oxq~(yw4RN!ټCt7@uQ9 EJWbr?0]/!
e=na_ s. # *F~K/654u; `*)` |28ap߷O@q# =
:a.܈lR>[bV1xWԩB6{Djt|M1iҧWJ={uX&"(w4ژn#5jLQbvVp6TFW@?`Q_|cFnG&Rr^ ;3i-IV!?#䵨SIPJq k*sQ1";rAZRz`VM|GlNgu]{)
kY~MV l:
ou
;tOAC^=V;`{4E6 F^-ma"I_ n)WǮ b j
舢iSmycAVbOFȩ6lq&m2s\ L}e)250}t?vBb m !#^21; t@*;x#QV@|1D$
FV i"l
(:m'Q7K'm ( 7_į,т괨cRShT;7B>cH"NJꠀ6v_4 !A9|XjߡO #m*n =*R0 )&@T J
5ދBveuH;Rm56'
w hSiQOD|$"
#~Spܕp<0MP :ulfPS bMzn2POL|z
c#x!kj`CLx^T EM} ؛'19U<:Lhjyvэ|#}ޘ:~2OAt`a@{ a۾OMpRߩ
T,F;`|&3E?7(E
\Otۮi SJo]2^h)`G $ jz
@ڂ$ecb,_ D8 W@ &$Jv% PvdsmU+^My %$
\umGFQ kN)+\*Aչ BA ;|98 4ě|msb/S:HJV7Ӧ:E~Xal\Q jS
Za lPrï*ZmCwlV&8S5; *~2; O#@w=< ;_ƀP
_|U;r
\V^m7 c W1 b;`wJM0;hȑM|!!=xIU
ѫO2
|qj=?Um(5 <1aӿl= 44˴^ K$w!"ҧۮ \5U]- oNIߦ۩ V'#HI$ ' ^v"'c$ܱZ` U@Į
[*1
@@?L0v؞,ѭhiF:SlD %H<)RŐbw hyW.qD܁$oQT8:7.bj OQ=J#~,EBS9y/-Nzo*~]KzPmi|?*";WƘcsR>!㌞>@Ѩ)N ,`5&$;`9knE>xXZ ګM3TۜKeڛ`vLtϿO&-I_6oYFQO< q}0Zc xEoPmSd!7lpd"ר\G,c)x;W}fсGhF0l 1oJVx6|~9 #.:+L^5P|kU)A$88cCŸ j0 WU' ČUT|bh :`٘C"UZb*`7O\c*<;`P҄
8
ZSMk+6ՔAN-[`? L
"0 JwAA|Cg# F"AQ} ߧO djiZp,R̆.
"ѕo}+n6u&I 8N @pTw Y
ĩ
$SRA>ؖ`\Ͳ VOZ`` d^5#'LOnlH:+SVo.P ^1d0Dc@ F<1h plC T6#``-5* :vQژ@w㊪o=nذ==`U: UA#T
19 I[ziC^|\t=GAj;c+P";c7`
#>6nǭq-
+_
cI~F&jv*Łe e!EA,ȭQu?<}I JHW~O~ 2jb0
~qL !#f۵p3 p5Ï˶AyF hęH=06 ] |d>`[h
5'z2
O@Xb}: bPaKèO~".> h0|C (ڃj Jazb !H |qD$
)X#RMA-BS{bNB1`|O 'z͔ LP9+wluX+@3E4;{u=U | 8F#F8(Fs hv%aӠ \KmSS)׃Pw SR8^JT J
:S!slI,{`GP^ğ `yTR0$
> 4kC Ά .%{ ߦm½Fn56= >$ Gm
#* ޟq^~Ei6 szW<3\#D,}L@*6g[|q
|4AVn>c87lY &*`+;@EGN6(0tF 4Q;P
1u"*OzѩҔ1Tw$qtG ƌQL V Xţpޠv
T6^R3*OlYT*<1UX!Je
C|1*z7~a^z8`Oj[q xboU?Ff@ 4 +,bzNF0;X<+̝?k O \Dxam[T CA?F ?݁7ܩA^ݎ@SFɈ=)N s5L/QMؠ83ffnL{&JN |(H֘ɾا*J~8v1u gC^>:*~x6
6*xW^G%:
틎<`E)/ /)ӂck (kָ&:q֜M~Zsxן.fgHmׇJ`8> k+Jˉ^]zoN|o LE=>cJ|^ozt-zS˶#i8Jo_\mn9ҟ NG*n<7>x]q^/O8Xޥwly0=ϏlU"{c
:c/>
endstream
endobj
51 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
8.9663 0 0 8.9663 59.7543 725.7825 Tm
0 0 0 1 k
0 Tc
0 Tw
[( eld)-534.2(was)-527.3(reduced.)-528.5(Although)-532.9(the)-534.9(transumbilical)-533.8(approach)]TJ
0 -1.2203 TD
[(leaves)-213.5(virtually)-213.8(no)-214.8(scars,)-213.7(in)-215.6(our)-207.2(study,)-215.8(a)-214.5(small)-207.8(port)-214(site)-213.9(scar)-215.8(on)]TJ
0 -1.2266 TD
[(the)-282(back)-285.8(was)-280.7(usually)-280.6(acceptable)-285.4(to)-281.4(patients.)]TJ
1.1128 -1.2203 TD
[(Agha)-299.6(and)-303.1(colleagues)]TJ
6.7246 0 0 5.9768 152.3338 696.8691 Tm
(8)Tj
8.9663 0 0 8.9663 158.3999 692.9006 Tm
[(considered)-301.3(that)-307.3(both)-301.9(transumbilical)]TJ
-11.0019 -1.2203 TD
[(LESS)-546.7(adrenalectomy)-545.1(and)-543.3(retroperitoneoscopic)-558(LESS)-540.4(adre-)]TJ
0 -1.2266 TD
[(nalectomy)-346(have)-338.7(signi cant)-344.3(technical)-341.1(similarities)-347.2(to)-338.4(standard)]TJ
0 -1.2203 TD
[(multiple-trocar)-211.2(procedures,)-202.9(resulting)-202(in)-202.9(a)-201.8(short)-204.7(learning)-201.7(curve)]TJ
T*
[(in)-221.9(experienced)-228(hands.)-222.2(Their)-219.2(research)-219.7(shows)-225.4(that)-218.8(both)-226(surgical)]TJ
0 -1.2266 TD
[(procedures)-200(are)-196.1(technically)-197.3(feasible,)-198.9(and)-189.3(the)-199.8(choice)-191.5(depends)-201.5(on)]TJ
0 -1.2203 TD
[(the)-193.4(surgeons)-187.8(pro ciency)-194.7(level.)-187.6(We)-188.6(have)-186.9(completed)-191.1(more)-190.6(than)]TJ
T*
[(900)-573.9(retroperitoneoscopic)-583.3(adrenalectomies)-577(\(including)-576(more)]TJ
T*
[(than)-285(100)-283.1(retroperitoneoscopic)-286.1(adrenalectomies)-286.2(for)-282.2(pheochro-)]TJ
0 -1.2266 TD
[(mocytomas\))-316(during)-319.9(the)-313.6(last)-314.7(decade.)-317.3(Therefore,)-317.1(we)-311.3(chose)-316.5(the)]TJ
0 -1.2203 TD
[(retroperitoneal)-455.9(approach)-444.2(in)-443.2(LESS)-445.6(adrenalectomy)-450.2(for)-446.5(pheo-)]TJ
T*
(chromocytoma.)Tj
1.1128 -1.2266 TD
[(Because)-225.6(several)-220.6(parallel)-226.6(instruments)-228.4(are)-221.4(inserted)-227.2(through)-225.1(a)]TJ
-1.1128 -1.2203 TD
[(si)14.1(ng)23.8(le)-319.6(a)13.1(c)0(c)20.4(e)0(s)17.8(s)-330.1(wi)20.1(t)12.2(h)-325.9(no)-316(ad)16.5(di)25.1(ti)15(on)19.1(a)13.1(l)-326(as)18.1(si)20.4(st)17.2(a)13.1(n)0(t)-320(t)12.2(ro)15.5(c)13.4(a)0(r)18.8(s)0(,)-320.4(L)0(E)25.6(S)0(S)-319.4(r)0(e)18.4(t)12.2(ro)15.5(-)]TJ
T*
[(pe)17.7(ri)21.1(to)15.7(ne)15.7(os)21.2(co)16.9(pi)20.4(c)-675.8(adrenalectom)9.4(y)-687.3(for)-686.8(pheochromocy)7.7(toma)-689.5(is)]TJ
0 -1.2266 TD
[(more)-443.5(challenging)-433(when)-444.6(compared)-434(with)-439(conventional)-440(lapa-)]TJ
0 -1.2203 TD
[(roscopy.)-319(The)-316.1( rst)-315.3(challenge)-314(is)-314.7(how)-317.6(to)-319.4(restore)-315.6(instrument)-315.6(tri-)]TJ
T*
[(angulation)-527.7(and)-530.7(minimize)-527(instrument)-530.6(crowding.)-521.2(Wen)-533.4(and)]TJ
T*
(colleagues)Tj
6.7246 0 0 5.9768 100.4031 499.6345 Tm
(24)Tj
8.9663 0 0 8.9663 110.2677 495.666 Tm
[(reported)-343.9(that)-351.6(the)-351.5(use)-350.3(of)-351( exible)-345.2(and)-347.3(curved)-346.4(in-)]TJ
-5.6337 -1.2266 TD
[(struments)-404.8(can)-400.5(decrease)-401.8(handling)-403.5(dif culties,)-395.4(reduce)-402.5(instru-)]TJ
0 -1.2203 TD
[(ment)-311.1(crowding,)-299.9(and)-309.4(restore)-302.9(instrumen)7.4(t)-310.3(triangulatio)8.4(n.)-309.8(In)-309(our)]TJ
T*
[(view,)-609.4(using)-608.4(one)-613.1(convention)5.7(al)-610(straight)-608.2(instrumen)7.4(t)-613.8(i)0(n)-607.6(the)]TJ
0 -1.2266 TD
[(dominant)-253.9(hand)-255.9(and)-252.5(one)-259(curved)-251.6(instrument)-252.4(in)-253.5(the)-256.7(other)-260.1(hand)]TJ
0 -1.2203 TD
[(not)-284.8(only)-286(forms)-281(a)-284(satisfactory)-279.3(degree)-279.7(of)-287.8(triangulat)8.4(ion)-281.6(but)-284.5(also)]TJ
T*
[(overcomes)-346.4(the)-345.2(operational)-346.2(inconvenien)8.4(ce)-346.9(caused)-345.8(by)-350.3(the)-345.2(fre-)]TJ
0 -1.2266 TD
[(quent)-414.2(crossover)-407.8(of)-414.2(two)-409.5(curved)-416(instrumen)7.4(ts.)-415.7(Moreover,)-407.5(our)]TJ
0 -1.2203 TD
[(choice)-336.9(of)-338.4(incision)-330.6(below)-334.7(the)-338.9(12th)-338(rib)-331.1(allows)-334.8(a)-334.6(short)-337.4(distance)]TJ
T*
[(between)-300.5(the)-294.6(incision)-298.9(and)-296.8(the)-300.9(adrenal)-294.1(gland,)-295(which)-295.7(may)-298.7(pro-)]TJ
0 -1.2266 TD
[(vide)-298(instruments)-297.9(a)-296.7(wider)-299.6(range)-292.4(of)-300.4(motion)-295(and)-296.8(overcome)-294.5(the)]TJ
0 -1.2203 TD
[(limited)-277.1(working)-273.8(space)-279.6(of)-281.5(the)-275.6(retroperitoneal)-272.5(approach.)]TJ
1.1128 -1.2203 TD
[(The)-328.8(second)-325.8(challenge)-326.7(is)-327.3(how)-323.9(to)-325.7(control)-322.7(the)-326.2(intraoperative)]TJ
-1.1128 -1.2203 TD
[(hemodynamic)-400(changes.)-393.5(Because)-402.6(it)-389.7(is)-396.9(dif cult)-394(to)-395.3(expose)-399.4(the)]TJ
0 -1.2266 TD
[(adrenal)-313(vein)-311.1(before)-311.7(tumor)-312.7(manipulation)-310.8(using)-311.2(the)-313.6(retroperi-)]TJ
0 -1.2203 TD
[(toneal)-294.1(approach,)-295.3(we)-286.1(did)-294.1(not)-291.2(painstakingly)-292(ligate)-295.9(the)-288.3(adrenal)]TJ
T*
[(vein)-355.3(early.)-346.1(In)-346.9(our)-352.6(study,)-348.6(intraoperative)-357.9(blood)-345.3(pressure)-354.3( uc-)]TJ
0 -1.2266 TD
[(tuations)-316.3(were)-305.6(usually)-312.2(transient)-316.2(and)-303.1(easily)-309.4(controlled.)-313.1(Just)-313.4(as)]TJ
0 -1.2203 TD
[(Kercher)-480.9(and)-480.1(coworkers)]TJ
6.7246 0 0 5.9768 155.0551 302.3432 Tm
(25)Tj
8.9663 0 0 8.9663 166.0535 298.3748 Tm
[(and)-480.1(Inabnet)-481.1(and)-473.8(associates)]TJ
6.7246 0 0 5.9768 277.3416 302.3432 Tm
(26)Tj
8.9663 0 0 8.9663 288.3401 298.3748 Tm
(re-)Tj
-25.494 -1.2203 TD
[(ported,)-384.2(early)-374.8(ligation)-381.6(of)-382.6(the)-376.8(adrenal)-382.6(vein)-374.3(did)-382.6(not)-379.7(avoid)-376.3(the)]TJ
0 -1.2266 TD
[(excessive)-343.1(catecholamine)-347.2(release)-339.9(caused)-339.5(by)-337.6(tumor)-338(manipula-)]TJ
0 -1.2203 TD
[(tion)-282(or)-281.7(pressure.)]TJ
1.1128 -1.2203 TD
[(In)-397.5(our)-390.5(opinion,)-403(suf cient)-398.4(preoperative)-396.5(preparation,)-401.8(close)]TJ
-1.1128 -1.2203 TD
[(intraoperative)-421.1(hemodynamic)-412.7(monitoring)-414.6(and)-410.6(management,)]TJ
0 -1.2266 TD
[(and)-429.5(meticulous)-428.4(manipulation)-430.9(during)-433.7(the)-427.4(operation)-431.7(are)-423.7(the)]TJ
0 -1.2203 TD
[(key)-356.5(points)-354.3(to)-357.3(reduce)-358.2(the)-351.5(risk)-357.7(of)-357.3(intraoperative)-357.9(hypertensive)]TJ
T*
[(events.)-425.9(Before)-417.7(ligation)-425.8(of)-420.6(the)-414.7(central)-424.1(adrenal)-420.5(vein,)-421.5(we)-418.8(per-)]TJ
0 -1.2267 TD
[(formed)-276.3(the)-269.3(major)-271.1(handling)-277.1(within)-268.9(the)-275.6(soft)-270.6(tissues,)-277.7(0.51.0)-161.5(cm)]TJ
0 -1.2203 TD
[(away)-359.2(from)-355.6(the)-357.8(tumor)-363.3(rather)-358.7(than)-354.5(directly)-362.6(manipulating)-356.7(the)]TJ
T*
[(tumor)-344.3(or)-344.9(adrenal)-344.7(gland.)-339.2(In)-346.9(cases)-342.8(of)-344.7(right-sided)-346.2(tumors,)-342.2(me-)]TJ
0 -1.2266 TD
[(ticulous)-355.1(manipulation)-355(during)-351.5(dissection)-359.9(and)-347.3(clipping)-355.5(of)-351(the)]TJ
0 -1.2203 TD
[(adrenal)-338.3(vein)-336.3(is)-340(necessary,)-335.1(because)-340.8(the)-338.9(short)-337.4(suprarenal)-340.1(vein)]TJ
T*
[(enters)-353.4(the)-351.5(inferior)-350.1(vena)-351.3(cava)-346.8(directly.)-352.9(For)-349.3(left-sided)-357(tumors,)]TJ
0 -1.2266 TD
[(extended)-252(mobilization)-252.2(of)-249.8(the)-244(kidneys)-249.5(upper)-251.3(pole)-247.8(is)-251.4(essential,)]TJ
0 -1.2203 TD
[(because)-189(the)-187.1(inferior)-185.7(portion)-192(of)-186.6(the)-180.8(adrenal)-186.6(gland)-190.9(lies)-185.3(in)-184(front)-184.8(of)]TJ
T*
[(the)-275.6(kidney.)-268.2(Fla)]TJ
6.1016 .0063 TD
()Tj
.4173 -.0063 TD
[(vio)-266.3(Rocha)-274.7(and)-265.1(colleagues)]TJ
6.7246 0 0 5.9768 217.9842 116.0504 Tm
(27)Tj
8.9663 0 0 8.9663 227.1118 112.0819 Tm
[(reported)-274.4(that)-269.4(high)]TJ
-18.6652 -1.2203 TD
[(retroperitoneal)-278.8(insuf ation)-275.7(pressures)-273.4(\(2024)-162.4(mm)-267(Hg\))-270.4(may)-273.4(be)]TJ
0 -1.2266 TD
[(a)-315.7(stimulus)-320.3(for)-320.1(increased)-320.3(catecholamine)-321.9(release)-320.9(and)-315.7(resultant)]TJ
0 -1.2203 TD
[(hypertension.)-590.2(In)-580.9(our)-580.2(study,)-582.5(pneumoretroperitoneum)-590.9(was)]TJ
T*
[(maintained)-709.3(at)-708.1(1214)-168.3(mm)-703.3(Hg)-706.2(throughout)-710.3(the)-711.9(procedure)]TJ
0 -1.2267 TD
[(without)-285.5(sharp)-284.5(hemodynamic)-279.9(changes.)]TJ
29.117 74.5598 TD
[(Our)-352.9(study)-358.3(has)-358.3(several)-353.4(limitations.)-364(Because)-358.3(this)-356.5(study)-358.3(de-)]TJ
-1.1128 -1.2203 TD
[(scribed)-271.4(only)-273.3(the)-275.6(shortterm)-272.4(outcomes)-277.3(in)-272.5(a)-271.4(limited)-270.8(number)-279.2(of)]TJ
0 -1.2266 TD
[(patients,)-423.8(we)-425.2(did)-420.5(not)-423.9(obtain)-425.1(enough)-426.2(data)-419.8(to)-426.9(compare)-418.4(LESS)]TJ
0 -1.2203 TD
[(with)-230.3(conventional)-237.7(multi-incision)-236.3(laparoscopic)-236.2(adrenalectomy)]TJ
T*
[(for)-206.3(pheochromocytomas.)-218.2(There)-215.5(was)-204.8(no)-214.8(recurrence)-213.8(among)-210(our)]TJ
0 -1.2266 TD
[(patients,)-721(but)-714.4(the)-718.2(follow-up)-726.1(duration)-716.6(was)-716.9(short)-723.1(\(mean,)]TJ
0 -1.2203 TD
[(10.5)-165.8(mos;)-409.2(range)-412.6(322)-168.8(mos\).)-409.7(It)-413.6(is)-409.5(necessary)-414.4(to)-414.2(observe)-414.4(pheo-)]TJ
T*
[(chromocytoma)-510(patients)-515.8(during)-509.6(a)-505.3(long-term)-512.7(follow-up.)]TJ
6.7246 0 0 5.9768 534.7841 653.0455 Tm
(28,29)Tj
8.9663 0 0 8.9663 310.8472 638.0786 Tm
[(There)-398.9(have)-395.6(been)-399.6(no)-398.2(previously)-399(specialized)-400.1(studies)-402.9(in)-392.6(LESS)]TJ
T*
[(adrenalectomy)-317.5(for)-313.8(pheochromocytoma,)-318(however.)-321.8(Our)-314.9(study)]TJ
T*
[(could)-281.8(serve)-280.8(as)-285.4(a)-277.7(basis)-282(for)-282.2(future)-288.8(studies)-282.8(with)-280.9(more)-285.5(cases)-279.5(and)]TJ
T*
[(longer)-280.3(followup.)]TJ
/F3 1 Tf
0 -2.447 TD
(Conclusions)Tj
/F5 1 Tf
1.1128 -1.8336 TD
[(Our)-321.2(initial)-327.3(experience)-326.2(shows)-326.6(that)-320(in)-329.4(properly)-324.6(selected)-323.4(pa-)]TJ
-1.1128 -1.2203 TD
[(tients,)-302.8(LESS)-300.1(retroperitoneoscopic)-311.4(adrenalectomy)-304.8(is)-295.7(a)-303(feasible)]TJ
0 -1.2266 TD
[(and)-568.6(safe)-570.3(procedure)-578(for)-573(pheochromocytoma.)-577.3(Further)-573.7(pro-)]TJ
0 -1.2203 TD
[(spective)-493.4(studies)-491.4(based)-488.7(on)-486.7(larger)-489.3(numbers)-489.2(of)-490.1(patients)-490.5(and)]TJ
T*
[(longer)-229.7(follow-up)-232.9(are)-234.1(warranted)-230.1(to)-230.9(evaluate)-238.9(the)-231.4(advantages)-233.1(of)]TJ
0 -1.2266 TD
[(LESS)-635.3(compared)-630.1(with)-635(conventional)-642.3(multi-incision)-634.7(laparo-)]TJ
0 -1.2203 TD
[(scopic)-279.4(surgery.)]TJ
/F3 1 Tf
0 -2.4406 TD
[(Disclosure)-336.7(Statement)]TJ
/F5 1 Tf
1.1128 -1.8336 TD
[(No)-281(competing)-278.2( nancial)-287(interests)-282.9(exist.)]TJ
/F3 1 Tf
-1.1128 -2.5924 TD
(References)Tj
/F5 1 Tf
8.4682 0 0 8.4682 315.0424 423.4959 Tm
[(1.)-501.9(J)14(e)12.8(on)-393.3(HG)28.8(,)-406.1(J)14(e)12.8(o)18.8(ng)-395.7(W)15.9(,)-406.1(O)17.8(h)-412.1(C)18.4(K)15(,)-406.1(e)12.8(t)-407.7(a)18(l)13.2(.)-406.1(In)28(i)13.2(t)14(i)13.2(a)18(l)-408.6(e)12.8(x)14.6(p)17.3(e)12.8(r)16.8(i)13.2(e)12.7(n)16.3(c)15.2(e)-409(w)16.2(i)13.2(t)14(h)-405.4(5)0(0)]TJ
1.2519 -1.2385 TD
[(l)13.2(a)18(pa)28.5(ro)28.9(e)12.7(n)0(d)24.5(o)18.8(s)14.3(c)15.2(op)22.7(i)19.9(c)-553.8(s)14.3(i)13.2(ng)26.1(l)13.2(e)-549.6(s)14.3(i)13.2(t)14(e)-556.3(s)14.3(u)17.2(rg)26.5(e)12.8(r)16.8(i)13.2(e)12.8(s)-554.7(u)17.2(s)14.3(i)13.2(n)16.3(g)-552.6(a)-557.8(h)16.3(om)30.2(e)12.8(m)0(a)29.3(d)14.9(e)12.8(,)]TJ
0 -1.2318 TD
-.0289 Tc
[(s)-14.6(i)-15.7(n)-12.6(g)-28.9(le)-263.9(p)-11.7(o)-28.9(rt)-262.6(d)-14(e)-16.2(v)-15.9(i)-9(c)-28.9(e)-248.6(a)-28.9(t)-244.6(a)-258.6(s)-14.6(i)-15.7(n)-28.9(gl)-15.7(e)-257.2(c)-13.7(e)-16.1(n)-12.6(t)-14.9(e)-16.1(r)-12.1(.)-260.9(J)-262.6(U)-15.4(r)-12.1(o)-28.9(l)-244.6(2)-28.9(01)-28.9(0;)-13.2(1)-28.9(8).4(3)-28.9(:)-1.9(1)-10.9(8)-28.9(66)-28.9(1)-28.9(87)-10.9(1)-28.9(.)]TJ
-1.2519 -1.2385 TD
0 Tc
[(2.)-501.9(Kaouk)-557.2(JH,)-554.2(Autorino)-554.2(R,)-550.2(Kim)-556.2(FJ,)-549.7(et)-555.7(al.)-549(Laparoendoscopic)]TJ
1.2519 -1.2318 TD
[(single-site)-253.8(surgery)-244.1(in)-244.9(urology:)-248.2(Worldwide)-251.7(multi-institutional)]TJ
0 -1.2385 TD
[(analysis)-338.2(of)-335.4(1076)-336.5(cases.)-331.5(Eur)-339.4(Urol)-332.7(2011;60:9981005.)]TJ
-1.2519 -1.2318 TD
[(3.)-501.9(Chung)-390.6(SD,)-388.1(Huang)-395.4(CY,)-384.4(Wang)-388.7(SM,)-388.5(et)-388.3(al.)-388.3(Laparoendoscopic)]TJ
1.2519 -1.2385 TD
[(single-site)-662.2(\(LESS\))-649.6(retroperitoneal)-664.8(adrenalectomy)-651.8(using)-658.9(a)]TJ
0 -1.2318 TD
[(homemade)-700.6(single-access)-700.4(platform)-700(and)-694(standard)-696.3(laparo-)]TJ
0 -1.2385 TD
[(scopic)-341.1(instruments.)-339.1(Surg)-333.3(Endosc)-340.8(2010;25:12511256.)]TJ
-1.2519 -1.2318 TD
[(4.)-501.9(Miyajima)-410.9(A,)-412.7(Hattori)-415.4(S,)-408.3(Maeda)-412.1(T,)-411.3(et)-415.1(al.)-408.4(Transumbilical)-418(ap-)]TJ
1.2519 -1.2385 TD
[(proach)-366.3(for)-365.4(laparo-endoscopic)-369.9(single-site)-367.6(adrenalectomy:)-368.3(In-)]TJ
0 -1.2318 TD
[(itial)-510.8(experience)-511.7(and)-506.5(short-t)-12.2(erm)-508.1(outcome.)-505.4(Int)-513.7(J)-508.2(Urol)-506.8(2012;)]TJ
0 -1.2385 TD
(19:331335.)Tj
-1.2519 -1.2318 TD
[(5.)-501.9(Zhang)-304.6(X,)-302.5(Shi)-307.4(TP,)-300.3(Li)-306.7(HZ,)-303.9(et)-301.3(al.)-308(Laparo-endoscopic)-308(single)-308.8(site)]TJ
1.2519 -1.2385 TD
[(anatomical)-473.2(retroperitoneoscopic)-482.8(adrenalectomy)-477.7(using)-471.5(con-)]TJ
0 -1.2318 TD
[(ventional)-681.1(instruments:)-687.2(Initial)-677(experience)-679.1(and)-680.6(short-term)]TJ
0 -1.2385 TD
[(outcome.)-338(J)-334.1(Urol)-339.4(2011;185:401406.)]TJ
-1.2519 -1.2318 TD
[(6.)-501.9(Walz)-671.4(MK,)-672.5(Groeben)-672.6(H,)-668.6(Alesina)-668.6(PF.)-673.7(Single-access)-676.7(retro-)]TJ
1.2519 -1.2385 TD
[(peritoneoscopic)-314.2(adrenalectomy)-310.3(\(SARA\))-305.5(versus)-306.6(conventional)]TJ
T*
[(retroperitoneoscopic)-302(adrenalectom)-12.1(y)-284.9(\(CORA\):)-298.3(A)-287.8(case-control)]TJ
0 -1.2318 TD
[(study.)-335.9(World)-335.6(J)-334.1(Surg)-340.1(2010;)-334.2(34:13861390.)]TJ
-1.2519 -1.2385 TD
[(7.)-501.9(Jeong)-249.7(BC,)-245.6(Park)-246.2(YH,)-250.4(Han)-248.3(DH,)-246.8(et)-247.7(al.)-247.7(Laparoendoscopic)-255.1(single-)]TJ
1.2519 -1.2318 TD
[(site)-434.4(and)-439.6(conventional)-436.6(laparoscopic)-440(adrenalectomy:)-441.9(A)-428.4(mat-)]TJ
0 -1.2385 TD
[(ched)-335.8(case-control)-341.4(study.)-335.9(J)-334.1(Endourol)-337.7(2009;23:19571960)-7(.)]TJ
-1.2519 -1.2318 TD
[(8.)-501.9(Agha)-364.3(A,)-365.8(Hornung)-361.5(M,)-366.2(Iesalnieks)-365.9(I,)-361(et)-361.5(al.)-361.5(Single-incision)-371.4(ret-)]TJ
1.2519 -1.2385 TD
[(roperitoneoscopic)-513(adrenalectomy)-504.5(and)-506.5(single-incision)-508.9(lapa-)]TJ
0 -1.2318 TD
[(roscopic)-339(adrenalectomy.)-341.5(J)-334.1(Endourol)-337.7(2010;24:17651770.)]TJ
-1.2519 -1.2385 TD
[(9.)-501.9(Luo)-384.3(Y,)-376.1(Chen)-384.7(X,)-376.1(Chen)-384.7(Z,)-376.1(et)-381.6(al.)-381.6(Retroperitoneal)-390.5(laparoendo-)]TJ
1.2519 -1.2318 TD
[(scopic)-354.5(single-site)-360.9(adrenalectomy:)-354.9(Our)-356.6(initial)-354.1(technical)-354.4(expe-)]TJ
0 -1.2385 TD
[(rience.)-339.1(J)-334.1(Laparoendosc)-339.7(Adv)-333.5(Surg)-340(Tech)-335.8(A)-334.6(2012;22:584586.)]TJ
-1.7473 -1.2318 TD
[(10.)-497.3(Lenders)-520(JW,)-516.8(Eisenhofer)-519.3(G,)-509.7(Mannelli)-519.9(M,)-513.5(Pacak)-517.7(K.)-511.6(Phaeo-)]TJ
1.7473 -1.2385 TD
[(chromocytoma.)-342.2(Lancet)-337.3(2005;366:665675.)]TJ
-1.7473 -1.2318 TD
[(11.)-497.3(Guerrero)-286.3(MA,)-285.8(Schreinemakers)-291.2(JM,)-278.5(Vriens)-286.5(MR,)-282.6(et)-287.9(al.)-281.2(Clinical)]TJ
1.7473 -1.2385 TD
[(spectrum)-637.5(of)-636.6(pheochromocytoma.)-645.2(J)-628.7(A)0(m)-637.9(Coll)-632.6(Surg)-634.6(2009;)]TJ
0 -1.2318 TD
(209:727732.)Tj
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(LESS)-340.8(ADRENALECTOMY)-336.4(FOR)-334(PHEOCHROMOCYTOMA)-26973.6(59)]TJ
ET
endstream
endobj
55 0 obj
<>stream
0 0 0 1 k
/GS1 gs
313.058 382.677 239.131 .45355 re
f
313.058 318.274 239.131 .45355 re
f
313.058 318.274 .51025 64.857 re
f
551.679 318.274 .51019 64.857 re
f
BT
/F5 1 Tf
8.4682 0 0 8.4682 62.022 725.7825 Tm
0 Tc
0 Tw
[(12.)-504(Tatsugami)-351.3(K,)-350.9(Eto)-354(M,)-352.8(Hamaguchi)-357.7(M,)-352.8(et)-348.1(al.)-354.8(What)-350.9(affects)-359.6(the)]TJ
1.754 -1.2318 TD
[(results)-352.6(of)-355.5(a)-356.9(laparoscopic)-353(adrenalectom)-12.1(y)-351.8(for)-352.1(pheochromocy-)]TJ
0 -1.2385 TD
[(toma?)-726(Evaluation)-733.7(with)-730.2(respect)-733.7(to)-730.4(intraoperative)-735.7(blood)]TJ
0 -1.2318 TD
[(pressure)-333.1(and)-339.1(state)-335.3(of)-335.4(tumor.)-334.5(J)-334.1(Endourol)-337.7(2009;23:101105.)]TJ
-1.754 -1.2385 TD
[(13.)-504(Thomson)-545.3(BN,)-546.7(Moulton)-551.2(CA,)-548.2(Davies)-551.3(M,)-547(Banting)-546.9(SW.)-546.4(La-)]TJ
1.754 -1.2318 TD
[(paroscopic)-705.5(adrenalectomy)-705.3(for)-706.9(pheochromocytoma:)-705.5(With)]TJ
0 -1.2385 TD
[(caution.)-333.4(ANZ)-339.6(J)-334.1(Surg)-333.4(2009;74:429433.)]TJ
-1.754 -1.2318 TD
[(14.)-504(Gagner)-391.6(M,)-393(Breton)-388.5(G,)-395.9(Pharand)-391.3(D,)-392.6(Pomp)-390.6(A.)-392.6(Is)-389.1(laparoscopic)]TJ
1.754 -1.2385 TD
[(adrenalectomy)-397.4(indicated)-396.4(for)-398.9(pheochromocytomas?)-403.8(Surgery)]TJ
0 -1.2318 TD
(1996;120:10761080.)Tj
-1.754 -1.2385 TD
[(15.)-504(Naya)-344.1(Y,)-349.3(Ichikawa)-343.6(T,)-351.1(Suzuki)-348.6(H,)-347.3(et)-348.1(al.)-341.4(Ef cacy)-353.3(and)-345.8(safety)-345.6(of)]TJ
1.754 -1.2318 TD
[(laparoscopic)-640.8(surgery)-639.1(for)-639.9(pheochromocytoma.)-651.9(Int)-634.2(J)-642.1(Urol)]TJ
0 -1.2385 TD
(2005;12:128133.)Tj
-1.754 -1.2318 TD
[(16.)-504(Toniato)-381.4(A,)-379.2(Boschin)-379.7(I,)-381.1(Bernante)-387(P,)-375.5(et)-381.6(al.)-381.6(Laparoscopic)-384.8(adre-)]TJ
1.754 -1.2385 TD
[(nalectomy)-245.5(for)-238.2(pheochromocytoma:)-256.9(Is)-241.8(it)-240.5(really)-244.4(more)-241.6(dif cult?)]TJ
0 -1.2318 TD
[(Surg)-333.4(Endosc)-334.1(2007;)-334.2(21:13231326.)]TJ
-1.754 -1.2385 TD
[(17.)-504(Ka)12.9(sah)15.1(ara)-349(T,)-351.1(Nis)12.7(hiy)12.5(ama)-347.7(T,)-351.1(Tak)15.8(ahas)13(hi)-352.1(K.)-350.9(Lapa)14.5(ros)16.4(copi)17.6(c)-359.7(adr)16.1(e-)]TJ
1.754 -1.2318 TD
[(na)14.2(lect)15.1(omy)-314.9(fo)12.8(r)-324.6(phe)12.9(ochr)13.6(omo)15.5(cyt)12.2(oma)14.7(:)-325.8(E)0(v)14.5(alu)15(atio)17.2(n)-325.1(o)0(f)-322(e)0(x)13.9(peri)13.1(ence)]TJ
0 -1.2385 TD
[(an)14.2(d)-333.3(str)18.4(ateg)14.3(y)-325(a)0(t)-329.5(a)-323.5(sing)13.4(le)-322.2(inst)17.7(itut)18.4(e.)-326.4(BJU)-319.1(Int)-326.2(20)15.9(09;1)16(03:)18.2(218)13.8(22)13.8(2.)]TJ
-1.754 -1.2385 TD
[(18.)-504(Shen)-331.7(WT,)-335.2(Grogan)-338.7(R,)-335.9(Vriens)-333.3(M,)-339.4(et)-334.7(al.)-328(One)-341.4(hundred)-332.7(two)-339.2(pa-)]TJ
1.754 -1.2318 TD
[(tients)-263.5(with)-268.2(pheochromocytoma)-272.6(treated)-271.7(at)-262.6(a)-263.2(single)-268.6(institution)]TJ
0 -1.2385 TD
[(since)-363.3(the)-365.3(introduction)-373.5(of)-362.1(laparoscopic)-373.1(adrenalectomy.)-368.3(Arch)]TJ
0 -1.2318 TD
[(Surg)-333.4(2010;145:893897.)]TJ
-1.754 -1.2385 TD
[(19.)-504(Nau)-428.2(P,)-435.7(Demyttenaere)-437.8(S,)-435.1(Muscarella)-430.7(P,)-435.7(et)-435.1(al.)-428.5(Pheochromo-)]TJ
1.754 -1.2318 TD
[(cytoma)-528.8(does)-535.1(not)-533.3(increase)-530.1(risk)-535.1(in)-532.8(laparoscopic)-533.7(adrenalec-)]TJ
0 -1.2385 TD
[(tomy.)-332.1(Surg)-333.4(Endosc)-340.8(2010;24:27602764.)]TJ
-1.754 -1.2318 TD
[(20.)-504(Wa)13.8(ng)-375.6(L,)-377.8(Liu)-369.8(B,)-377.8(Wu)-375.3(Z,)-376.1(et)-374.9(al.)-374.9(Com)15.1(pari)18.3(son)-372.3(of)-375.5(sing)20.1(le-)13.2(surge)17.3(on)]TJ
1.754 -1.2385 TD
[(se)13.7(ries)-264.3(of)-275.1(tra)15.3(nsp)14.4(erit)16.6(onea)12.3(l)-274.7(lap)15(aro)13.4(endo)15.9(sco)14.9(pic)-269(sing)20.1(le-)13.2(site)-267(sur)14.9(ger)12.5(y)]TJ
0 -1.2318 TD
[(an)14.2(d)-594.4(sta)12.9(nda)15.7(rd)-591(lap)15(aro)13.4(scop)12(ic)-587.5(adr)16.1(ena)13.6(lec)14.4(tomy)13.8(.)-593.5(Uro)15.6(log)14.9(y)-592.8(201)13.8(2;)]TJ
0 -1.2385 TD
[(79)15.9(:577)16(58)13.8(3.)]TJ
-1.754 -1.2318 TD
[(21.)-504(A)13.5(f)0(a)18.6(n)0(e)15.7(h)-325.1(C,)-314(A)13.5(u)0(l)17.1(l)-321.5(MJ)13.8(,)-319.1(G)0(i)16.7(m)0(e)17.4(n)0(e)15.7(z)-323.5(E)14.9(,)-325.8(et)-314.6(al)17.8(.)-325.8(C)0(o)23.9(m)0(p)15.2(a)0(r)21.4(i)0(s)20.8(o)0(n)-319.7(o)0(f)-315.3(l)13.2(ap)15.1(ar)21.4(o-)]TJ
1.754 -1.2385 TD
[(e)12.8(n)0(d)17.8(o)0(s)19.7(c)0(o)20.6(p)0(i)17.1(c)-306.1(single-site)-307.4(donor)-316.1(nephrectomy)-307.3(and)-312.4(conventional)]TJ
0 -1.2318 TD
[(laparosco)9.7(pic)-376.1(donor)-369.7(nephrectomy:)-371.9(Donor)-377.7(and)-372.6(recipient)-370.6(out-)]TJ
0 -1.2385 TD
[(comes.)-326.9(Urology)-327.9(2011;78:13321337.)]TJ
-1.754 -1.2318 TD
[(22.)-504(Toniato)-294.4(A,)-292.2(Boschin)-292.6(IM,)-294.3(Opocher)-293.4(G,)-288.8(et)-294.6(al.)-294.6(Is)-288.7(the)-291.6(laparoscopic)]TJ
1.754 -1.2385 TD
[(adrenalectomy)-437.5(for)-432.4(pheochromocytoma)-440(the)-432.2(best)-437.9(treatment?)]TJ
0 -1.2318 TD
[(Surgery)-334.3(2007;141:723727.)]TJ
-1.754 -1.2385 TD
[(23.)-504(Castillo)-338.8(OA,)-334.6(Vitagliano)-339.2(G,)-335.7(Secin)-339.7(FP,)-339(et)-341.4(al.)-334.7(Laparoscopic)-337.9(ad-)]TJ
1.754 -1.2318 TD
[(renalectomy)-343.2(for)-338.7(adrenal)-338.7(masses:)-341.2(Does)-342.3(size)-343.4(matter?)-339.7(Urology)]TJ
0 -1.2385 TD
(2008;71:11381141.)Tj
27.8905 48.1757 TD
[(24.)-504(Wen)-343.4(X,)-342.6(Liu)-343(X,)-342.6(Huang)-341.9(H,)-347.3(et)-341.4(al.)-341.4(Retroperitoneal)-350.4(laparoendo-)]TJ
1.754 -1.2318 TD
[(scopic)-756.2(single-site)-755.9(ureterolithotomy:)-763.3(A)-749.7(comparison)-757.1(with)]TJ
0 -1.2385 TD
[(conventional)-362.9(laparoscopic)-353(surgery.)-362.3(J)-347.5(Endourol)-357.8(2012;26:366)]TJ
0 -1.2318 TD
(371.)Tj
-1.754 -1.2385 TD
[(25.)-504(Kercher)-342.9(KW,)-341.7(Novitsky)-337.1(YW,)-340.2(Park)-340(A,)-339(et)-341.4(al.)-341.4(Laparoscopic)-344.6(cu-)]TJ
1.754 -1.2318 TD
[(rative)-595.1(resection)-595.5(of)-596.5(pheochromocytomas.)-604.1(Ann)-596.6(Surg)-594.4(2005;)]TJ
0 -1.2385 TD
(241:919928.)Tj
-1.754 -1.2318 TD
[(26.)-504(Inabnet)-369.8(WB,)-362(Pitre)-367.8(J,)-365.3(Bernard)-365(D,)-365.8(Chapuis)-367.3(Y.)-362.7(Comparison)-372.3(of)]TJ
1.754 -1.2385 TD
[(the)-619.7(hemodynamic)-618.7(parameters)-617.9(of)-616.6(open)-617.7(and)-620.3(laparoscopic)]TJ
0 -1.2318 TD
[(adrenalectomy)-384(for)-378.8(pheochromocytom)-16.1(a.)-374.7(World)-382.4(J)-381(Surg)-380.2(2000;)]TJ
0 -1.2385 TD
(24:574578.)Tj
-1.754 -1.2318 TD
[(27.)-504(Fla)]TJ
2.6712 .0067 TD
()Tj
.4151 -.0067 TD
[(vio)-437(Rocha)-430.6(M,)-433.1(Faramarzi-Roques)-439.6(R,)-429.7(Tauzin-Fin)-438.3(P,)-429(et)-435.2(al.)]TJ
-1.3323 -1.2385 TD
[(Laparoscopic)-699.4(surgery)-699.4(for)-693.5(pheochromocytoma.)-705.5(Eur)-694.2(Urol)]TJ
0 -1.2318 TD
(2004;45:226232.)Tj
-1.754 -1.2385 TD
[(28.)-504(Goldstein)-280.7(RE,)-274.2(ONeill)-283.9(JA)-273.7(Jr,)-274.8(Holcomb)-282.5(GW)-275.2(3rd,)-276.1(et)-274.5(al.)-274.5(Clinical)]TJ
1.754 -1.2318 TD
[(experience)-605.4(over)-608.1(48)-600.1(years)-604.6(with)-603(pheochromocytoma.)-611.8(Ann)]TJ
0 -1.2385 TD
[(Surg)-333.4(1999;229:755766.)]TJ
-1.754 -1.2318 TD
[(29.)-504(Scott)-368.6(HW)-367.2(Jr,)-368.6(Halter)-368.6(SA.)-368(Oncologic)-370.5(aspects)-376.2(of)-362.2(pheochromo-)]TJ
1.754 -1.2385 TD
[(cytoma:)-252(The)-250.6(importance)-254.7(of)-248.3(follow-up.)-256.6(Surgery)-253.9(1984;96:1061)]TJ
T*
(1066.)Tj
8.9663 0 0 8.9663 441.5243 490.2802 Tm
[(Address)-339.4(correspondence)-340.1(to:)]TJ
/F10 1 Tf
5.1342 -1.2203 TD
[(Xiang)-336.7(Chen,)-334.3(MD)]TJ
-2.3015 -1.2203 TD
[(Department)-337.8(of)-336.3(Urology)]TJ
-8.6118 -1.2203 TD
[(Xiangya)-335.5(Hospital,)-336.1(Central)-340.5(South)-330.6(University)]TJ
9.2062 -1.2266 TD
[(No.)-332.4(87)-334.1(Xiangya)-335.5(Road)]TJ
1.606 -1.2203 TD
[(Changsha)-335.3(410008)]TJ
4.8813 -1.2203 TD
(China)Tj
-10.0281 -1.8716 TD
(E-mail:)Tj
/F5 1 Tf
3.2626 0 TD
(cxiang1007@126.com)Tj
/F3 1 Tf
-8.8584 -4.2933 TD
[(Abbreviations)-337.5(Used)]TJ
/F5 1 Tf
8.4682 0 0 8.4682 375.6472 358.7527 Tm
(CT)Tj
/F11 1 Tf
1.4795 0 TD
()Tj
/F5 1 Tf
.9373 0 TD
[(computed)-333.7(tomography)]TJ
-3.3541 -1.2385 TD
(LESS)Tj
/F11 1 Tf
2.4168 0 TD
()Tj
/F5 1 Tf
.9373 0 TD
[(laparoendoscopic)-343.8(single-site)]TJ
-3.0461 -1.2385 TD
(MRI)Tj
/F11 1 Tf
2.1089 0 TD
()Tj
/F5 1 Tf
.9373 0 TD
[(magnetic)-337.9(resonance)-334.1(imaging)]TJ
-2.8252 -1.2318 TD
(SBP)Tj
/F11 1 Tf
1.8879 0 TD
()Tj
/F5 1 Tf
.9373 0 TD
[(systolic)-335.7(blood)-333(pressure)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(60)Tj
49.7234 0 TD
[(HE)-329.5(ET)-338.7(AL.)]TJ
ET
endstream
endobj
59 0 obj
<>stream
hbd`ad`ddrvvL) 0q6q57+i ^!FR :"~|WXtesWnXr)R'5f+jjXؾJnUi
'뒗HO4n}vµsp6yA%ݭ|?t~[tּ+kf./=Kǫa3!25^@df d]R
endstream
endobj
61 0 obj
<>stream
hTP1n0
):lx u]hW@M <'E #wl\atdApr֙wͬ$%衮L%7'l MpW"5 "T4`q=p3,?cn-.AdMB=HFY6mD٬<9+>|^į i
endstream
endobj
63 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
66 0 obj
<>stream
hޔWitWK@2R՜*$ 1@0xl˖dٖmYZevɒw+Ƌlcl0 ;&a B'3p:0))ICL:s{uw}cvDo{
Yek0:Yz o 0k_Mc=557Xb8{kq
k%vF"YXH<
V Dx# X0dƷO8"$[ȾUY4sYYmمOmy[[9kt==~D?ο7 WlnMsjx=3W?^q
@
Fvs9y&Us_ Z \]赋Ergv K? Ԁn" 2̤al_Kw]t]uF;^gß%/ހraGW彜_Ww;wtVw˧zYBc@x:~1[7۠V ƭaGl6U-0? GGqfQri=
]ed=^ѿcٷVBͰND' ;[p~Bn=gY|G>* LA
&'dڼ d-奼vcEnZ
5;ƪr("AuWѽi bq˦,<,~p쭛ĭC! !XpO{ !0A88z#ۇ`fxF"1!BE"" DZţ?gSf^>`ʡH*7Eú%d/0
: A,
߁߃u'o(,'|yX ez$?PUV]TWy-8<b1!Fb"ƍ 7t|>Xd@f%ޜ*4IתrBh? 1(C-*VoWۚo3x ȯ>N
^|Zm Q<;SL" ̚.a j!
Dm.%
`Z$i mAg zZo*%6Q>CMA l9|HQ;k&P
DYl-"l3$a-ʰ*\ ^0^]N)=&lFٸ(d\(
Ӊ/ޯ{fk =JI#RєTʒXL>e]> Di-#/+QK|#,с*boe.Eq<'9Ľ T-pK^ՍH~\~Nr;sJb`}y5r# $X:}Rfq zZ^JlTNT#EcH *IhM1
UdW2:և,(ЃAX(4"=_dS)o]_kы!WIM(*I{g;"T?x&f#e!]N5Mح3T!P箱70ⶃ;o?s3Tfˁ=1ҰE2G\ ?cAZIs@GF[vG'?FpހӇvRd@q@VjW 84$ ł_ފ3lVBKjpC{`bxD5Ӄ__ ys
5 WШ]/+uw s]4>ŀ5e =î}g~͎GV3hk<ݜf_#곩U dC c7syq %ai i 5' Ff]~-@%b4+.dMm`ƌY#g%KˋTf# oC =dK)YJm d -:pM lk֡-A'~}7~'uYA@$tMB
5Tkĺt]*Le4[B5ClsÑsvszU&f %y) 1@Y)pZ {giw墻wegfZ'94kT"M%؝(
#p JY ;"Eɋ
%11 w k6~= ꏫ7S>stream
8;Z\7CRTku%-0,AbPfaBf3&pNSHP_7G.WbV"WrFi*0LRi\,tB?MKWbf8'Q%/([Vlh
G)Ogc&FOinA!X=t'rW"tY93N$%tE^p4743H>eB$9kUc@[mbeE]3lM#?fE-+\l?DX7
&ZWYY8S.-&l-(5'BJ;Oc>jWt"*96&48RtlC4K.=QRVk;;kUNRs17P?kDe)&(7eK&:
VtWqfY1=QNM8:9g:X+f'STC_WWsQu`DRhnMYL+Ng;t(K'039^#h0G0M?8:*fV+5Y",KRNP9?kS>.+t,A?=R,t;#LPT
;k@2;1,@r]fiRXmf>pu+0=?rC='ZsC]t`XYNCN..H:]`"H0KV%Q8]&[2t7gM9<\BI
+a??-ERWp6TY0iRktg6_f+@VE43#QB>PN4/LB$BZ`-Yiok'a('Do^0(.Q25a~>
endstream
endobj
31 0 obj
<>stream
8;Z\7D0"qr#kVR%O8ElS
R@X)X4/7&dr8mfF<&=KSYVO]+MTsFRr)`#*O7bC!'A(dpVrm"Z=#V@bRU#Hl_H3Et
,[Z*fLe.*3'N?t%2d?bXT2pTsii[+-M(`!H(H5LY*1*A(%Ha\363R[o\m@CH0p3cE
V3-pqBi,pkN>.`;W^/*i#uS@!\QYO5?uQO>O=adp2RH9:F-^bGe0+-I)Y4_k&Jn>Q
n2JSo!GNn4k9$CO#!6[b6*`>Mf:/R1:fOlf0XQ;2V&R-TmLeO&!m@-S^C+SmorP-k
b/B1s;GW"ndpQ?:)k@b"fLVV[Of,_Ep0t&3lC@2l]2jgeW>)k"?un/$D)IB.f]#hD
!+D.I^[:Xa7:2ca.UYTqV,;fK%R'68=7hC$QUE33Pn922@pf^PBkJO3a%^-"pu=JUuHTW]1-MMu72Fj>q,A^UAQ@,c.Z.BGaI
/e(qi?d@>>*h=hI'B,mm!Y8PhKDd+f'TUP>ZXJab0J)H4U"k>_ABS6=$ZdV>07)OI;@Oj6QFaM(b^Gk?U7gUM*
D1:mlbau0WB'9%!D.u1/cgNqgp?jKO[;H=FZ36T0^\5('r>P`V:D,J~>
endstream
endobj
47 0 obj
<>stream
8;Z\7>ET(3#kThHj$)8=qrBqIB,srnI)',:aiB.cCt3-5Y\DgG%H/*b!Lp:/"(:`V
O,!g&o]Z8&a1rpI$1Itcpc7N[WIU0$kP->M7iSVP+<9#^=\;3c"HRL*$a,Ym6'Z3p
FO9RrET%3?8,Q9FX3621>T$cD\t4/'02-aJ>?p6?3&!#;E)G_,*tp8`Xe,BF$_j]n".+364BoeGF"8RK%>>VDpQT(Fe^5N!CsAdlDpQf)6>d[,.FMdb&#
L9()_[o$Maf4+aD74]!-5Hjp:&gmWVpo6,_JpQfk@<285iTkUb4a^E,Hg/1)E>aZG
n(jK*2::-9Fbm<_?].mkp6hopr=+ENN8-H99qh@6Sb(7)0Bopi2>%i8[G/TgkG+"i
EUUK6EgGYml^BJY\@utZc
)>!j@AM
endstream
endobj
52 0 obj
<>stream
8;Z\7dC+]N#kVX#NW9"oIcoPj$l9U,lY5U.[PkI3)Fd-m`J"TbI7C6Egu`+5Si:,PV4"dM"p>WnlS_jhT+[3AN%BUMgTr]
i'J71PcXsZ@t!a&\UT$*rYD`E;.&VfF4@^.=[7D+)Csf7GZu*0c)c[EQ&g!7AR^e*
/O#l8k3?l>X5aG+ld2?!0k7aSbkVeqUT^)5f?'?=AW+(&@qbDG2sRU8Yr:kpMN#0Z
\l,V@U?Tj6mND-KMq9.V+&c[Ol$a5r5(/.R,-UbX#HDU=@IT]old(\O(\DfH)i__:
Hgf%fY3B`=)#(!0$/YuqhkaX*I$J2.F=o]/JQDCH_@4e:rM^lJbh!l<.)PWhW"2Vt
>,SV_i"#)Dfj^:$s(&%d+30dYo6gkmg/6+dMAAe
>Pq3R@=JFsWW!S_,BUYq`b:d_K]f)-D_NXJ:)`&g@fOmR7afnfZP5$5S@WXK.fb00
b]%&C.(l86-Rs1iY!#/'^He;qWL\-sLE>`obq[j8Ag5Yd4$8uA=8]/ZmlA\fO5aOE
,hG1l18SCM:^oo,[F(N@Nq;p`n,AGTU3(aWd9%pu`O.l/U6]XKTG8YKh_b*(i[_1H
W+l<=)f\bMXSD(`-ta;.HS?6$bZ>`9nLFaeSB4H#;p:!Ef;X&?nFp%'nc_ueE8AM0
;O-SP>_Otr[0FUMCXKo,MBHOKBBq5bT@0(K8egt=pPSe+[bqfn;lI+#[+;?EomXTU
qJp_>D4NtFCMuJ=;[&sr[iR0fV?ZiLIZ]K%!~>
endstream
endobj
56 0 obj
<>stream
8;Z\76+2D"#im]-k5K#P3kp4hM+ZJ?J(m];f31$9(^?/'0$FaU?h_]4,7Wk;po[Qt?)(AdNqE%BihF6"m]6iTl.^!@RBN!-rXO1od
ZBaUd.UBra$#S(Mp-#JD0S[d\of*od5Nur?]>e0\gS"%-Jld5>;rn#Y?Fh<$rfMbB<'
[h;%_ago2>2WCX0'>@odcQ,fr2V'>emHre*/Ce(aKlQmkaT$4+:D1C]h>9X"(U\KZ
?OI5L$O[=M$O[=M^VSe-Ojt5r~>
endstream
endobj
71 0 obj
<>
endobj
72 0 obj
<>stream
HtTMo0 W jId5!Ň}tQbJ؆ Oxa~g7,aI1E+$,e!U"P",$
~=;>ޙnƝl3OȨ$&Xo%h|NufJVq*,ORFYVɤ^ն7>ƻ3"䔓1,"qMۻk!E_$2V @z 2h]
9{96M gJln]Ȱ" ξqG/nx272O
YQ%D}M8L WSo@y!N8<*pSoM6%i &88 ҂p*Cǐ^@ CV C3ȋmKwh38t|#g;z0%dAFTFBb+s4ḕ 2hi5pC#O7pBVY?-dgt`g:pA
}LyҒCئAƷn;_ I&
endstream
endobj
73 0 obj
<>stream
HlTn0+|H1EJz, Zߊ Ȥ@1#JCoKr;38% 9U<۟rA}!7o4:5f JI})<5U `a4BWi&TC߱<1iX DyXD +ubj)@{WK_v9My *a7OCj*K6"1p :l9WpI,Vh456h;3Y_H;5I+G>cc\j -Ej V]Zq s#S&%9P r
endstream
endobj
95 0 obj
<>stream
hbd`ab`ddpvwvL) {X_~^$ W L lLVس{U'~ &H(c)?B~,b-a!{/\
Ѷͫ3VP
pmywӳg>G [g~uaqiB~~]q9:[{0}ӿ"@rž|B[
i @ D
endstream
endobj
94 0 obj
<>stream
hTPKk +渥
$RȡmNRQC}դ)=(fx=vFou 7 Wד
_SB09
+$F8]K8P`p`}VEM<Υ FRnD ~ A)bE$r,iwl]EٴrU/Dir6 r؏ -bvi
endstream
endobj
74 0 obj
<>stream
HT]o0} V/ ǖ!Bo mҸj܍^εW> /{ν^Se̗flڱXZs W?\, 7
S
ۉJX)
W4px.Hnي q
Zĩub)]U)"auBO)Wn3t~ (ϊWzj.jm%Q_ǛɎ[V(}[Wɶv8%.Cl.Hѹ>볭:7@haӚ"4;NR,\눈 jSZ!n{#&sC. Um@Ϗ?.F\'XdĊ֤fUݤDUBPo2{וJB&,]DrhM 8ѲmSBtb
!lACybN%i,ь4Od*j
E#1nF
. d!ba65=S 0aS4 Vcp4i"R?tQFw,.t` -57/U7l8ѹ$ &īUP }BOÓ Tϛi2ږ+eRZZ ۏW`E|Я[䱁ݖJ_MVg\Ckl<6>7mއ)I* ԫ4 -cW(\
=@c" 3L8-S2C/d)+RT `> Cq7# x
endstream
endobj
75 0 obj
<>stream
HtTMs Wf"ʗ ڏdzoiD6 T$]i'e Xqʇ9|{&PMvRjjJ1,%vK܌1K s
0 xJi 1 *]eGO ǻ_UÛñv)3O)B&4!W}*!]xE<\ُe2=Uۗ H@aD1-e.IXs\+tyIXkQLf!Z5̾65 ݺ/v)8 g힋R=8&jHƀ ٧K6ݘLK%ɚQ ʄhHrq9OH75]T]OdUCͰ TF ?<tRg<@Shz z
4n
YF7|G1o]%D~
#_m~SLanH->F,j_In? Nj
endstream
endobj
76 0 obj
<>stream
HlTM #92HB˛s<0g@2[CvCFwʥI_Uu8 .RW8 "cK2`K-qh#%vɵXg=$̺wU]ho F~t?Ȧ岭ۃ@Uik8Oɚ Qa)ێJr*^ Ok;R1ψ+C3x3x=e#lO 6 j dAf zo"3mf؈#D셖$fro=П+;+3.OSpY\X= ^-n%"_\E0#d?{/¡k):j5T]4(RYNeiǓoy%7(
ǍutpF{}DuKN6' ?dbF!eߐ*3ʞ5XM_=`VAԲ#- ~ 0 ݙY
endstream
endobj
77 0 obj
<>stream
HlTMs G>⎭1!iz봇fzoM#f$P]d&ރOwqCH݉Bp6C#4_p.͞7B(9~&yGUc3ub?Q7 _! hj
8/#g :sb1Bb
9]<:Ypr bD:7S7IF#V߳=W
R
+s:Ch1cGD[",C
ޗJWL9 ٤_ؗmK(i-9f"88"]6lUU{l:ښ"*vGZuJ\5xx
7!
cx+D)GDŤ똖wG @N.;:<ӆ$8Z^`t۽[d L]U)TUX20/ U$iC>!hy v0
|Wt4iԡUu
\S"&%7#hٱf)s4]c1 vе ]r 7VդZ}a(= b5-7XOwt}}h&^"E/4vdw!&`p_)D_}J˭>C"WHY>!g 8$x9!ɓ6 k
endstream
endobj
78 0 obj
<>stream
HtTMo0 G 9CZ ȹ[Q P.6AXc.#xkFEM=ضwvoS{T<l Ob#*Ley$k,
*[=pFc&6fs0Zlzʒ8*ej> 2u[g6tEV0{psHbs (0~N m̕lBO@>\#jؑUV2=v`K.g,`tȱ2À I#/vKsRu ]4`}k'^Q83& oC5pb
A<Q}GрS h ڛL@֩g&RYT%x .C4`IQ LTO0KYۜ5MKϾQfM dߌ w'M"HpIȌ7Izh Σ(B5w::= ;Qb7#+-5ߠ[Mf$~ 0 e]
endstream
endobj
79 0 obj
<>stream
HTSR0+Gw4BZ>aC28L~ ѯx{se9Ӝ<A+Jd\J
.
2ɄuD/aB# ;3RHR%vU\7!ݐq& > sb3\14 . 4o
L˧')#$KM8 ۇ GU}Py}"uҘz2u7|Rv۪R &$nPp5W]Ruj]N6/Xrsɑ`B*G-NL|͖y$>stream
hdU TSg~?hkx8'@A.T]@Pp%6cSb2EqAqV*XŪV@[c2 ]Μ3ܛ~wyJjCI$!a ڼӬ2GA) u@5fap Y8ne#T
g
)I9Dwkigi}gNz5fҳD!SoHi'|@Z!_Di.-Od |!AKO0|dJ>ǘB $Oms5)ڔC.{5P5 ERjbK)j.MK([*VJy8PRJF9P1T\b/ɓ\j3Focgnc[l[m+iT'Nt"8(b$e --WU
*"?b|e wAf0 }ehf"jW{"X9,0C-
̢[3{[w*o5DD. J;C@[%]!y,N.{oo ;Pb70Raӗ0M0~:d|R }b)3 +KVe^\ X
H
ۀG|_\X}N5tHGєEKSq`$扮9{eY
GU,RE
\?.[eȹ;mfxقjE/7*t{p}/A5"ƹ]pl=_z3ht/\lrMZMX&/u0j҂i!X61 1f҇Gi !ye*T%F{hX c b!`r*2Ÿ` %^
v77aDzM%'/q6]Lx8A@ąAzLơ r]XrK4ςV9s>x\)W $J+OP P9Qh;+6j<Ȗ/y>bE&FeO8m^
;b"
^ɷ~|X(`5D ߮."qW²\DHXCƙ@Uvƕ%ہ Qb$(mAOXKNO81x9 MPnB8{a$v!Wv]:ę`, |pӦ%x{w'OGZ%[OlI=m'ܘ Y 9 GYan nR6ϚV-|!ybr
9]\ u]F6ܚnw,AlO R/;ω֮6&( vrJ9\bUy]X[_bֵwY7XL9]ed/&%]lLߠEXZo:[n<{I51:u e a4H8`H#Ch{⩤vMewUWATɂxKep'H >{^6"}r}cDR@&qPQʤ2 넸 R
դ{-+ܴpraa jID^D>stream
hY TS[I=ǡjUG P @d! A!LaLr8'!a0 2Xj_kCmz o
e{[Y :{k+[+kk;[1 x6B{ MI# ?聯}xVV|#&ϷZ%X%ZYmA[ZVVZVOXO^alo"6C Fڞ}MƔJ^>{DMwf`
SAu@FS\ veJn$$n;<>{}gXwoJ zb..GCmRccq19`k1 mc@[R1A, 8J֭Ö~?C !GCw5#~HөMY5Zݹeƙti]L UAL 1kkLUY%J:VK7l0됿-2L ?u mWe`7?U<<;[ Ci8̤-ăŋ̞9) STW]O "D~2dq ? 8υuzJ
rJNN`.$D fB:^)lnF^`-|(@E r&b X!hM] u?,88>+.7 *}FOw9l%!&r V 1X`3A7!{y.x]_bɀH(@y+Jǁ#swpc m^2#^{ۆgl LQ/Mu &e"i E~iw7 )7%PEXJArqhCCG^miޞ;/ @7,':o:Ɉ
`=
1"`m(HO\Cg"'wY)YO*#bc"5姭=@ahӕr
:x #
}1 g0OtnFBqPY&J.W֤~G1AJUt*"ٖliaVg o<S;R yݳ_Z4KC14.dVNKu@"UrB?_D { LX*
-lskl
yJ;S+b8Zu;D x/n(77x8ve(CvEء ?\*u[5olZA/9bǃʚΠ6s^Z"; 䦝Rsp> "1gfI1^Nz'uDڟ1[{m"QL,$ބ6.d`HWR)HM4m䅛 ܸ&O\P-I^ iԋɧLF\[ߚCoRhKet: Ӣikrml%ed4*Q2Dtb04_;NYexC3~TwMqwɭ uS`R+de]_SE2qg ! Klrv^nИ0Cb/RRq[H4d>K](+Zw;^p*XZ G0 fGUu=lC6e֫1ח%|Y9|; 3iRe>we3 }AvۣEAsAaL"aKβ4XقI)a [m"}f>#A
**-!e 7&8VfcL%v5W>ϼ}I,> *b2L Ŗ(Օ5E&Vau8 'e FDEBaBU{l3Uu2|כ{%$?;3&#$%U_ \Qm9`i0 8, 0 O[8ŋ
`Alog[K%kkqpP3wvu=.d?,>H* '|8x)-Gg $+HGq p/0&.N7`e8Rm ,a`/PE^o6h_Kb8E7 @:QfAd ͍AhI V_AquA|G TWk ȱmxGqϤj5ɴ4SȹdaiLYlI4qŊ8>[YV cBEr Fʏ/{x X?US±; /?t6K%q8K*bZBapj8{7071|xs:3+Xݓ嚶 x5F♷u5É4 UyUt+j֨^ԝBx[uq*8& DJbb v'7r9yy7s!6Ldu5T#D65[i LI8̀pToZ7# ۀ s
u9y¢.K.Ue$''HH]EQAJH8O%Rvۑ3M~EA
M"$*ho"*ISsVy #e1u{B ApEѶO v,|[mUc9edp9WG
,s!CCStxrHl+t%Ӏ xJ}.UސR)d~ɡ<0FEh ̱'ʼC =I\ /{`#q &3O!dyDV*U"1ֈ-S;S?K Ld>?| q\!7
X Ϣ T 5:OH]#"S)1 |bH~6snWA.elJcQ$ J)sh(H 0kz-&xC$di &yk%H }\CC*UR0 OǶvyaZ~xq8N`P]T
r0KE@Tw
$f("6'I=hOI<42g,59#!A,VRbbdy6ӏs).OU4h&7Ct{MM q,m?j>ˍǮnpXEF,YuSjt, Z
-#,lA |v0qQ3ҌZ}n+/~J'L.LKl R:g[r:-֥qabW9!dd6kd_jYi{5 ,!21LLa ;@7v/BCM5fsI&Gd5r3-$>`Ӡ-1jJ\RS C`TtEtž* ~jЈ}}mYh_D nsy* GxN:qpɼő^5wlգ{[?p/b .q!1Z'{/ 'XNɘF ̟ FN} 3'z0Φ ,w
$fϙ 6 # A`g|_!U=i2Hn`' F3b!)
j*L DY|
GW̄Ev[wS.NS#lYkp`^nLO/tŶl"3LOʘ
mqwCc0=iͨ'q &MxC-ёa9i1:,]uR6УL&0)^T kmu5#0KTxҝTT-.Vm ۰93 Zmn=q'J~}ZiD5p TChvv#7sTR,-1VA$U A1矀od`mxTN7lP(⃔"c1 ҒGu!qlEM
4=n5Li)\5rb(0,-Eu\='^HHˁpCSp2Z={b 8{,:stKokf
hl`!\Kn{A"Db xI,yv>stream
hޔ]HSqϬsN L ͒0C"T!e3͵2t .>3wradYT}bvEU7#" ޫyy^=l}&H6 +)9]h0.smL _HZNv 9?gqI$,KŶaYv, e쑤^!@´ ⃒xN \ 1eQ*>jUC7u?OB$5 -'\x= ]SΞzqsUQVox #' sn8ofxT33sK*.RqdV_ }1jq8,:<1LΆ#GMw4;(j,aSJF2bzlNبS:hT-f{ct( $ Ϩ A5sv^i
iHv S轮+.
@`A%pD]GXm5UI:Z{A$V3ZJe֓s >mTwR<
Q',n |
IWۈK J1b
endstream
endobj
99 0 obj
<>stream
hޜU{PSW 77([1ǽ'[]]jjSK"* $B !!,E $@W}tn]:iwwNsiggg{}qDE2 6'>XэVŭRK "tޝd%9wߏV߆tnB&2"Hf/ssܧ]x܃ʹj\WΞ
F[I\,6Yڄ nsMƇ
vǩu&G)n5X Bd58
=\\f7i7k
6L]%NlpM·#&~f90 0O(&93b8 f
30&9E=5.cCT[T r }NQ 3[ǻm|~\]g\k9>rI4 |
%*s>7-Wt@% A`tDՖ˝j<7Wq
N%a51)k 69hbk}c\d|;{& 2 "`$r,za[N`#
|P[4D}v#YOyRkݿygR8XTS)VRZ}L!'O5LX8 {4Դ]AM9lN*7
v6oZSRlѣQc0% $r~J)m`v%PbOTylyK7\{Bt)CZu
ߤ Y<:/hN Pgn`gf;FO>ʠ$⦞ӝA40NIl;K4/*Ph$ITi0dw`" !TS.V)~KdWFGG-qq(ƒx~K+\xC]
4 pkx"(s7G&\PH Qkb؏wo e:
ZhYGc]?tIϬdٳ }OX 7U;)xyzl!Q%wT*6 _^̈4*^b:Ȣ TrR 5fgj]O(eD063SsMMX]NVBp<*P9<6١yO7ytPhE Y
Awr߁UԤ
O'-&G_l+g =6.I4[]
qhhae
NS0S:W˛_.ɷ NN (#=MhE
|N1H ݀P- `LQ6jh<+>f'4BwY]5vtS}!OLzZ\{= *C>6F Fc HS3n>alu_ qtuxh2ʠ7ۥ *joxn%ױ2*UQ0v
!I
R}ʚ}W{.)4&J儻Ό]K'b SDn|)jׁ4HqI%Y݃8 Ӕ5OYߓ9}!Vz߹I9
OUAE~0V+םܻA\
?^w
*rwd^ /QKvX
2]^6t@6+ks9#'#x ~{K mѷo=|ȂDE߉#wޟVz3~n(ۀ"j i ; \7%%Z
].6Zٺ#u {' (*E N*2;EF6*=0/n<*# >TQP%+*KuS`/Ox;1 ZiB#Bz}Zg7ඖ:>%vUү!ŝ88Xy
`}8VWռtB8TXr hg$ M`cE G>ovd(=*/^֧kA/YL[?3B/86x9@o.MuV$ .mEs]Pfeg lCmYMpy_ [
endstream
endobj
100 0 obj
<>stream
h|V TWm@]Zո@d&"J %(nhf0%ƀ,AƨF0z
bcBD1*yż&gę33_zw} ! $ɫ3gΘ554XcX0Z۪$C͖1YDRV oHK]~=ylкe\x! Dci.0h7gJQ
0pDPa EC{ΰػ
Z1 tyO,d 0n#(/']fPH78
8ٵx卜{v6]S p_%d~
\GmBvc3y$<"yNH)a'sw:( 9\`zb*mcܢsm e@6s=`Ě0/kbZN8*2kilyo`£}gF.
0-˗I|3wmZȻS3rT., | I S@ɕb<9{cȿK\:Da虫'), БhAA G%T?^!
~ hdQ+p?Lg! v..EIz3@yE(VHHF ^/(թ0 ~ my2hbLNe Y´.SNG)xх/D.^JqA
gȡ 㴱o s
9P:Pj;R Ժ I0}O'
#n1C*XɄг|{8Ѵ5s;})g LkHJ:h\dzN)
Iu= Uc|xYUBA H>YFMG+ cDnH]nPtɀEL}` .8\d4=џS7dc
xc6]4@
r @ u cԲ)<ΣG<} NXhʦQ)b $ i~fxb<'s IIq$R11${LxHov֧7gqb>'&ܾu\riYM|Ki%6W`|/غ4йLW<qЎLowXFWOl@R룊2)[J茏 0 | BaA #3BA:qS:0|,Nd(}up,"ݦ} p9έTwՂ(? ~:c%e\G~3 R6M3\z/ LVb} 8v*SG;%ZTaobRLJ{ /RݫݹcwaO['2+3w.v+X{ }b6ln.^zĥnALBXw<"`Wo)6 o*ɥg|6vEث`_aDhր|Ç;
v}'qJ?º$|7yQ//9(n5&h8lc9 _ 5 o !=T [ l =ev94醊jeWVC_ݔ0b/ב3_,YZ>stream
hތmLSgǟ *-0 .*J'cӂFH YYed a8C0LSVDQPqdY|EQP!bn8\,SHss<痜CPj8?O^kr/" n_+=d ;2< WG(DSHHnMm ٮH=N\\. [Hc0z
UOCfLPa cV0+C)I ~gFGU$؛@
~'%p xU_f7lTdGh0;
!AGKߩ"B r&{}NzL+/R ,m|}SQQwkN_쥆.ߗ|A*("IG`]\X 1vз{hOt7V' TH̀\tڄv P[Ñ͛ tמC8ԓzӡC&?-}(Y$W@!f
2.
endstream
endobj
102 0 obj
<>stream
hތyp+/M*JnkR&ҴL!
!`0cc[KӲd]֭He K%Om !)mH!mfYi2M?:{{6HJo6)eػmNJq
dbպmOگ O` @F"/@ I :&KXN,Oǚ5_$1 `A'섞xkE>SWyp>" L;ɫ2
(ėF:qQb\ l :ȡ('LRMf}2?w B9XV}:Jb9b QL\pڡ2) zV }`/F11Ь I#3Rtՠyn<ΘLxVmѹ:kwk'v;^\p9[mQT2Vs.ɹ|qF
4*,ŲYv u|Dnq#tp<
LCTҼVn5z -4:qãu7Gk x][@Ev %"O&6csapRkJ; iz5C,7)
stdk)
nsŅщkKO(h]Yn n/HǏt_m %ݠLp2]* %)b=BχIȈrr<(xD\zq SP DQ҇krE}"f$jlP"ÞZvG%*3xds*ʭ$x( ,*P/54 vc3"(enUkm ڍ5m~[I;@mz.oKx!8(HCwYz SE#,(|=xWxp:Vr昴OuO@ޒ:GJƙM l,/x,$ܰ)Ο!JT/Q]cXK?W*R
Et,xo1T * :Qal$pO'?drgzof/^IK 7g |t
wgoɗupZݛ 1U?-[z=Ƌ,V?~ų AȅpNa Kē/3R& k135ć_9UW֔ *MmvьDU:\YH>)"2Lm_ֹ h 3757wjE$:3 ZBR,X m>^E -@
\Ĕe ;pwvDȅ:Z5ne6M1( j+7/.bɿu;ca|! K*+zc}S>66 V/]\Nr+ X.j5Nw ]ުI~b\6+t:;G79]q!x1Jl0݂L|t&2yK n!bt7|~_(rviG44>ozDpS Bk]u8{Vjb1GSws`gi6A3eOհUlU å&ڢ}h(8wMbVuEUn'5$"^4QI r,;ad=ѫSssH/4,san: c#Mf+ #W6Y&*^[%B
|N 9^V`p9꛴\ r4
`塜2Pȑh Z*pv*j҇qςDtǨk5PuKb&s'E\i ~C>YݮW76%
ّOdf!PQ vwGg$\NPp> JRP`יTRCN-O|]LĐ^W/V 駈G? j4
endstream
endobj
103 0 obj
<>
endobj
17 0 obj
<>stream
xZmo۶+ᢥHP^4.[-'l+,ݯsbɒR'{a8(ysH10@@(,T B &LOcB! }&B0@,HEXţV2)Ǣ mXGexWx[uE1 -^+b3
SPg~JX,A? TkB!%nbK"d1m X |WG*¢XҞddޓ="DT X K/ƒ]GRX~O6_XU0]gs/bjZ
%_ ֹ~`z֟e3lQs/n7kFWEgMϳu)+tU3?;2~=TvhہmWMhAog
%)D2Xd{P,xbL9 Ƅ%dG5{ZCz=8(3DKD.
=p^OY'T-& |i{GzJ"۴^tg)x7?Az6on+D'Uh|,k3QzMUEɇf
a]!s.3>=,: +.B_wUȧ)H
YhY{ О/s~xx[+7 :^$n {F5zMR'AXr^(@je6_;PGԍGX[.9/
x\ trʾlҲ0zp 6
+/܍§&
X8* 3oQ>g YqC3 fC64; `S wQa idHZ7|i\ !| > oiee^̸laAWV~ŭi(VMD` E{o xW?@SL
p mm2vKۛc$OB
ܜUD%aԂ{cf'İ1@_S}f:+1zF>4v s7 iNcW[%my_lݏlM+p9Tbu+ ɯu%
0] T|\@-{\ˮܮN75vC)?2w smaciy \[#InS! _\^ S'8iU`2SXeO\QdO "q̬ L|杺\sV#kQVun0MIF :__ U7moF~ozRXlMv+jc f'@ vpz ;^l}M {K,A06ܨ
*= ^ g <)I
Z
λZfN&O־yOzm[!=9Ƭx'th2"z6[#8tVCtҮWQFW
QWfz(uGXz< +ZIu(s4
or?#Us={L}W3Ө] k]ҩ锏Q$7(MP _(1=JSԠ~?_U)AM9jk%UZ +գ`= owK3*T-.
U@0Q Odb߸"W6}]j Vg^Y#{@MYfWeA3( ѶzAT/ŞOߐGVfڗMQefx:Tu~Z?JH>M8Aj IpDo %ȨIb'
,fe:_OYQ-:N:
ݬnr\7P whmXpbv>%lonݹ ᨾ59akOb&<uRF"{R;duٗ2ȶMVQ 8aDtBV
~SfPbɋr6+j'Ŏ)ϋ=^Շl8X+ž>{04w
ja >]'=zQ>,m<+_MHųKԎɒT\Z ]ZdCn O,{!K~
L˭Jp, T}qsh~5FҲɓ%;Ţϝ=LJJa
Bڢg酈 MJ^K.Ţ"_`3)ƖO 54 <z0F?!Q)xm{4X| [ {5D֒Ebd js
8J#OWt]4 6`(mҿZ h!~y
Slṕʁَy/k,ȍS~;ʩ-d)aW)c5lJh`Bc>f3vm=u>F7%VB
endstream
endobj
104 0 obj
<]/Root 71 0 R/Length 332/Size 105>>stream
x-9KCQ1bD<5.(\@biaz+-l\B؈)ID?P2 n1 .^fS%'b")ϡMö}-~ ( 8Z
2x~P;ŶXtyTkk.OҰᒈZpQP1Wѐ)/g/\.l.}WC{iv:J Yr =߮@=MS. E'<<;3ܻ]6)
endstream
endobj
startxref
170454
%%EOF